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1 Background 
The ICES Working Group on Pathology and Diseases of Marine Organisms 
(WGPDMO) provides annual reviews of national reports on the disease status of wild 
and farmed fish and molluscs in the ICES area. In 2004, the group published a first 
report collating this information from 1998-2002. This second report aims to provide 
an update on the status of the major diseases described in the original report and also 
to provide an overview of new diseases which have emerged since the previous report 
was published. 
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2 Viral Diseases of Farmed Fish 
2.1 Infectious salmon anaemia 
2.1.1 Description of Agent 
Infectious salmon anaemia virus (ISAV), the causal agent of infectious salmon anaemia 
(ISA) is an enveloped virus consisting of eight single-stranded RNA segments. It is 
classified as the type species of the genus Isavirus within the family Orthomyxoviridae. 
Differentiation of ISAV isolates is based on sequencing a highly polymorphic region 
(HPR) of the haemagglutinin esterase (HE) gene (Kibenge et al., 2007). All clinical iso-
lates have deletions (HPRΔ) in this region while isolates which do not have deletions 
in the HPR, (HPR0), are avirulent. It has been shown that HPR0 ISAV is widespread in 
farmed Atlantic salmon, Salmo salar, (McBeath et al., 2009; Christiansen et al., 2011; Go-
doy et al., 2013). 
2.1.2 Geographical Distribution and Temporal Trends 
Clinical ISA has now been reported in Norway, Scotland, Faroe Islands, eastern Can-
ada, the eastern USA and Chile. ISA occurs each year in Norway; the number of cases 
varies annually with 15 cases reported in 2015 (Lyngstad et al., 2008; Hjeltnes et al., 
2016). Between 2001 and 2004 an ISA epidemic occurred in the Faroe Islands almost 
wiping out the Atlantic salmon industry. An ISA contingency plan was introduced in 
2005 with the result that no clinical outbreaks of ISA have occurred since then. As part 
of the plan, all Atlantic salmon going to sea are vaccinated against ISA and a large scale 
monitoring programme involving monthly samples from all sites is in place. In Scot-
land, an ISA outbreak occurred in the Shetland Isles in 2009 (Murray et al., 2010). The 
disease was eradicated with the result that Scotland is once again declared free of ISA. 
ISA outbreaks occurred in New Brunswick, Canada and Maine, USA between 1998 and 
2004 (Gustafson et al., 2007), but there have been no outbreaks at these locations since 
2007. However, outbreaks were reported in Nova Scotia and Newfoundland, Canada 
in 2012 (OIE, 2012). The disease has been reported in farmed Atlantic salmon in Chile 
since 2007 (Godoy et al., 2008; 2013). 
2.1.3 Short Description of Clinical Signs 
Infected fish are lethargic, congregate in the upper water level, gasp at the surface, go 
off feed and hang motionless at the sides of the cage. Affected fish may exhibit exoph-
thalmia, ocular haemorrhage, distended abdomen and/or skin haemorrhage. Internal 
pathology may include dark, pale or yellow liver, ascites, pale gill and heart, enlarged 
spleen, petechial haemorrhage in visceral fat and a darkened foregut. Low haematocrit 
values (< 10) are a typical finding. Histological findings include multifocal haemor-
rhagic hepatic necroses that may become confluent to give the changes a “zonal” ap-
pearance, leaving areas around large veins intact (late stage of disease development). 
Focal congestion and dilatation of hepatic sinusoids, sometimes with distribution as 
described for necroses (early stage), and rupture of the sinusoidal endothelium with 
the presence of erythrocytes within the space of Disse (early sign) are also observed 
2.1.4 Control/Preventative Measures 
According to the OIE International Aquatic Animal Health Code and EU Directive 
2006/88/EC (detection of HPR0 ISAV is not reportable in the EU), ISA is a notifiable 
disease which means that specific eradication protocols have to be implemented in ar-
eas which have been declared disease-free. In Canada ISA is reportable under the 
Health of Animals Act. ISA control plans are based on active surveillance, vaccination 
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and eradication of infected cages. These measures are supplemented with increased 
biosecurity, disease free certification and a greater traceability. The virus is known to 
be susceptible to a range of common disinfectants (Smail et al., 2004) and to ultraviolet 
irradiation (Øye and Rimstad, 2001). 
2.1.5 Other Host Species 
Clinical ISA has only been reported in farmed Atlantic salmon, however the virus has 
been found in marine farmed rainbow trout, Oncorhynchus mykiss, without visible signs 
of disease. Virus can be detected in wild salmonids only and to date there is no evi-
dence that the virus is present in non-salmonid fish (Raynard et al., 2001; Plarre et al., 
2005). 
2.2 Viral Haemorrhagic Septicaemia 
2.2.1 Description of Agent 
The causative agent of viral haemorrhagic septicaemia (VHS) is a rhabdovirus of the 
genus Novirhabdovirus within the family Rhabdoviridae. It is a single stranded, envel-
oped, RNA virus. Sequencing of the VHSV genome has revealed four major genotypes 
(Snow et al., 2004; Einer-Jensen et al., 2005): 
Genotype I: Danish freshwater isolates (I(unclassified)); predominantly continental Europe 
(Ia); northern Europe marine (Ib); continental Europe (Ic); Scandinavia – Baltic Sea and 
freshwater (Id); Black Sea region (Ie) (Cieslak et al., 2016). 
Genotype II: Baltic Sea marine isolates. 
Genotype III: North Atlantic marine isolates. 
Genotype IV: North American Pacific coast (IVa), Great Lakes (IVb), North American 
Atlantic coast (IVc), (Cieslak et al., 2016). 
2.2.2 Geographic Distribution and Temporal Trends 
VHSV has been isolated throughout the Northern Hemisphere from a wide range of 
marine and freshwater species (Studer and Janies, 2011). VHS (genotype Ia) was re-
ported in a rainbow trout farm in England in 2006 (Stone et al., 2008) and an outbreak 
of genotype III VHS occurred in wrasse species (ballan, Labrus bergylta, corkwing, Sym-
phodus melops, cuckoo, Labrus mixtus, goldsinny, Ctenolabrus rupestris and rock cook, 
Centrolabrus exoletus) held in a marine hatchery in the Shetland Isles, Scotland (Munro 
et al., 2015). In 2007, the virus (genotype III) was detected in three marine rainbow trout 
sites in Norway (Dale et al., 2009). There were two sites positive in 2008, one in 2009 
and the country has remained free since. In Finland, VHS (genotype Id) continued to 
spread after its first isolation in 2000, with 24 farms reported infected by 2004 (Raja-
Halli et al., 2006). Denmark has been declared free of VHS after a long term eradication 
programme, with no clinical outbreaks since 2009 (Bang Jensen et al., 2014). In N. Amer-
ica the majority of isolates belong to genotype IVa (Garver et al., 2013). In 2005, VHS 
(genotype IVb) occurred for the first time in the Great Lakes Basin, North America, 
affecting a number of different species in Lake St Claire and Lake Ontario (Elsayed et 
al., 2006).  
2.2.3 Short Description of Clinical Signs 
The clinical signs of classical VHS in freshwater salmonids are dark skin and pale gills, 
petechiae in the gills and in the skin, and haemorrhages in the orbits and exopthalmia. 
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Widespread petechiae developing to haemorrhages are observed in the peritoneal sur-
faces, in the swimbladder, in the skeletal muscles and in the meninges. The liver is pale 
with haemorrhages, and the spleen is often enlarged and reddish. High mortality is 
observed in the acute phase of the disease. 
The clinical signs vary among species of marine fish. In Pacific salmonids, VHSV was 
isolated from fish without clinical signs. In Pacific cod (Gadus macrocephalus) and her-
ring (Clupea harengus pallasi), infection appeared to be associated with skin lesions, 
while other Pacific fish species from which VHSV was isolated did not display any 
gross clinical signs. In European waters, the clinical signs in farmed salmonids and 
turbot, Scophthalmus maximus, were almost identical: classical signs were observed in 
freshwater salmonids, whereas VHSV in most other fish species was isolated from 
specimens showing no clinical signs. 
2.2.4 Control/Preventative Measures 
According to the OIE Aquatic Animal Health Code and EU Directive 2006/88/EC, VHS 
is a notifiable disease which means that, should the disease occur, specific eradication 
protocols have to be implemented in areas which have been declared disease-free. 
Strict biosecurity protocols are essential for remaining disease free. Øye and Rimstad 
(2001) demonstrated that VHSV is sensitive to ultraviolet irradiation. 
2.2.5 Other Host Species 
VHS virus has been isolated from 48 different marine and freshwater fish species in the 
Northern hemisphere (Skall et al., 2005). The updated annex IV of EU Directive 
2006/88/EC lists the following species as susceptible to VHSV, herring (Clupea sp.), 
whitefish (Coregonus sp.), pike (Esox lucius), haddock (Gadus aeglefinus), Pacific cod, At-
lantic cod (G. morhua), Pacific salmon (Oncorhynchus sp.), rainbow trout, rockling (Onos 
mustelus), brown trout (Salmo trutta), turbot, sprat (Sprattus sprattus) and grayling (Thy-
mallus thymallus). It is likely that wrasse will be added to this list in the near future 
(Munro et al., 2015).  
2.3 Pancreas Disease 
2.3.1 Description of Agent 
Pancreas disease (PD) is caused by the salmonid alphavirus (SAV), a member of the 
genus Alphavirus of the family Togaviridae (McLoughlin and Graham, 2007). Based on 
sequence analysis, six subtypes of SAV have been reported. In general, SAV1, 4, 5 and 
6 have been associated with PD in Ireland or Scotland and SAV3 causes PD in Norwe-
gian farmed Atlantic salmon (Fringuelli et al., 2008). SAV2 has been associated with 
sleeping disease in freshwater rainbow trout, however it has now been isolated from 
diseased Atlantic salmon in Scotland and Norway (Graham et al., 2012).  
2.3.2 Geographical Distribution and Temporal Trends 
Pancreas disease has emerged as a significant disease of farmed Atlantic salmon in Ire-
land, Scotland and Norway (McLoughlin and Graham, 2007). The disease is endemic 
in Ireland (Rodger and Mitchell, 2007), and has increased significantly in Scotland as 
well (Lester et al., 2011). PD is a listed disease in Norway and an endemic zone was 
established for SAV3 cases in 2007 (Jansen et al., 2010). A second zone was established 
for the newly identified SAV2 in 2012 (Hjortaas et al., 2013). In 2015, there were 137 
cases of PD registered in Norway (Hjeltnes et al., 2016). There have been no reports of 
PD in Chile or North America. Sleeping disease of freshwater reared rainbow trout has 
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been reported in Scotland, England, France, Spain, Italy (Graham et al., 2007b), Ger-
many (Bergmann et al., 2008) and Croatia (Vardić Smrzlić et al., 2013). 
2.3.3 Short Description of Clinical Signs 
Early clinical signs include a cessation of feeding, lethargy and the observation of yel-
low faecal casts in the water column. A small percentage of survivors typically fail to 
thrive and become runts. The changes most commonly found in clinically diseased fish 
were severe loss of exocrine pancreatic tissue, cardiomyocytic necrosis and heart in-
flammation, inflammation of the red skeletal muscle and degeneration of white skeletal 
muscle. Muscle lesions are typical of hyaline degeneration with swollen fragmented 
eosinophilic sarcoplasm, central migration of myocytic nuclei and subsequent invasion 
of the sarcoplasm by phagocytic macrophages (McLoughlin et al., 2002; Taksdal et al., 
2007). 
2.3.4 Control/preventative measures 
Pancreas disease was listed by the OIE in 2014 and is a list 3 disease in Norway, but is 
not a notifiable disease under EU Directive 2006/88/EC. A commercial vaccine is avail-
able and is widely used by the industry (Bang Jensen et al., 2012). Regular screening of 
fish is recommended using serological (Graham et al., 2003) or molecular techniques 
(Hodneland and Endresen, 2006) as an early indicator of infection. Strict biosecurity 
protocols are essential and the salmonid alphavirus is known to be sensitive to a range 
of common disinfectants (Graham et al., 2007a). There are also indications that selective 
breeding for resistance to SAV infection is possible although research is still ongoing 
(Norris et al., 2008). 
2.3.5 Other Host Species 
SAV has only been isolated from farmed Atlantic salmon and rainbow trout. The virus 
has been detected by PCR in wild flatfish; (common dab Limanda limanda, long rough 
dab Hippoglossoides platessoides, and plaice Pleuronectes platessa) off the coasts of Scot-
land (Snow et al., 2010) and in common dab and plaice in Ireland (McCleary et al., 2014). 
Bruno et al. (2014) demonstrated that SAV5 isolated from common dab, off the coast of 
Scotland could be grown on salmonid cell lines. 
2.4 Infectious Pancreatic Necrosis 
2.4.1 Description of Agent 
Infectious pancreatic necrosis (IPN) is caused by a double-stranded, non-enveloped, 
RNA virus of the genus Aquabirnavirus. Aquabirnaviruses infect a wide range of fish 
species, aquatic molluscs and crustaceans. Seven genogroups of the IPN virus have 
been described (Blake et al., 2001; Nishizawa et al., 2005). 
2.4.2 Geographical Distribution and Temporal Trends 
Historically IPN has been a major problem for freshwater salmonid aquaculture, how-
ever with the expansion of the industry it has emerged in the last twenty years as a 
significant disease of marine farmed Atlantic salmon. In farmed Atlantic salmon, the 
disease has been reported in Scotland (Bain et al., 2008), Ireland (Ruane et al., 2009; 2015) 
and Norway (Hjeltnes et al., 2016) where genogroup 5 isolates are the dominant form. 
The number of cases in Norway is decreasing, with 30 cases reported in 2015 (Hjeltnes 
et al., 2016) and in Ireland there have been no clinical cases of IPN since 2012 (ICES, 
2016). In contrast, IPN has spread from the coastal region of Finland to inland areas 
since 2012. Both genogroups 2 and 5 are found in Finland, however only genogroup 2 
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isolates occur in the inland areas (Eriksson-Kallio et al., 2016). IPN has been present in 
Chile for many years where most isolations are genogroup 5, but genogroup 1 has also 
been detected (Calleja et al., 2012). Genogroup 1 isolates also dominate in Mexico (Bar-
rera-Mejía et al., 2011). Although clinical IPN has not been recorded in Australia or 
New Zealand, an aquatic birnavirus which clusters with genogroup 5 isolates was re-
ported in Tasmania (Davies et al., 2010). 
2.4.3 Short Description of Clinical Signs 
Diseased fish usually appear dark with abdominal distension, particularly in fry.  
Swimming behaviour is lethargic: a spinning movement (whirling around the longitu-
dinal axis) is characteristic.  At necropsy, petechiae in the perivisceral adipose tissue 
are the most consistent lesions. Fry often show pronounced ascites, whereas post-
smolts usually have little or no ascitic fluid and a remarkably dry body muscle. A whit-
ish liver is most commonly found in fry. In the acute stage, extensive necrosis of the 
exocrine pancreas is the most prominent lesion at histopathological examination. In 
these lesions, individual acinar cells are seen at different stages of degeneration and 
cell death. Also, foci with necrotic remnants of exocrine pancreatic cells appearing as 
an amorphous eosinophilic mass are often found. In liver tissue, similar foci of necrotic 
eosinophilic hepatocytes may be found. Usually there are small necrotic foci in the py-
loric intestinal epithelium and cell debris in the lumen of the pyloric caeca. Some indi-
viduals develop a chronic disease with fibroplasias of pancreatic tissue and emaciation 
(Roberts and Pearson, 2005). 
2.4.4 Control/Preventative Measures 
The disease has now become so widespread that it is no longer listed by the OIE and 
very few countries perform screening for the virus. The inland area of Finland has an 
IPN-free status for genogroup 5 IPNV under EC Decision 2010/221/EU. It is common 
practice to immunize smolts against IPN before going to sea as a control measure in 
combination with selective breeding and stricter biosecurity measures. Compared with 
other fish pathogenic viruses, the IPN virus is more resistant to inactivation (Smail et 
al., 2003., 1993; Øye and Rimstad, 2001). It is however sensitive to a number of com-
monly used chlorine and iodine based disinfectants which can be used to inactivate the 
virus on equipment and the surface of eggs. In recent years the number of cases in 
Norway have reduced which is believed to be due to the use of more resistant strains 
of Atlantic salmon (Moen et al., 2009). 
2.4.5 Other Host Species 
Aquabirnaviruses have been isolated from a variety of wild and farmed teleost fish, 
molluscs and crustacea in freshwater, estuarine and marine environments (Hill and 
Way, 1995; Ahne et al., 2003). 
2.5 Viral Nervous Necrosis/Viral Encephalopathy and Retinopathy 
2.5.1 Description of Agent 
Viral nervous necrosis (VNN) is caused by a piscine nodavirus, of the genus 
Betanodavirus from the Nodaviridae family which are small, non-enveloped RNA vi-
ruses.  
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2.5.2 Geographical Distribution and Temporal Trends 
The disease has been commonly found in the Mediterranean region. Over the last dec-
ade nodavirus infections have occurred in marine fish farming in Norway and Scot-
land, most notably in turbot (Johansen et al., 2004) and Atlantic cod (Hellberg et al., 
2010). It also occurs on the Atlantic coast of North America (Johnson et al., 2002). 
2.5.3 Short Description of Clinical Signs 
Clinical signs are associated with lesions in the brain and retina and include failure to 
control movement and swim bladder function.  Sight and colouration are also affected, 
however the most significant outcome is mortality, particularly among larvae (Mun-
day et al., 2002). Mortality has also occurred among harvest size sea bass, groupers and 
Atlantic halibut and may be related to elevated water temperature. 
2.5.4 Control/Preventative Measures 
VNN is listed by the OIE and is a list 3 disease in Norway, but is not a notifiable disease 
under EU Directive 2006/88/EC. In the absence of vaccines or treatment, biosecurity is 
the most effective way to limit the introduction and spread of nodavirus within popu-
lations of cultured finfish. 
2.5.5 Other Host Species 
VNN is associated with mortalities in larvae and juveniles of several marine species 
worldwide, including haddock Melanogrammus aeglefinus, Atlantic halibut Hippoglossus 
hippoglossus, Atlantic cod, turbot, Gilthead sea bream Sparus aurata and sea bass Dicen-
trarchus labrax.   
2.6 Heart and Skeletal Muscle Inflammation 
2.6.1 Description of agent 
Heart and skeletal muscle inflammation (HSMI) is believed to be a viral disease alt-
hough the causative agent has not yet been conclusively identified. Studies have sug-
gested that a novel reovirus, termed piscine reovirus (PRV) may be the causative agent 
(Palacios et al., 2010). Direct localisation of the virus in heart tissues of HSMI affected 
fish has indicated an association of the virus with HSMI. The virus has also been de-
tected in healthy farmed and wild fish sometimes at elevated tires similar to those 
measured in fish diagnosed with HSMI (Garseth et al., 2013). The development of HSMI 
may involve environmental co-factors which influence the pathogenicity of an infec-
tious agent (Løvoll et al., 2012). 
2.6.2 Geographical Distribution and Temporal Trends 
HSMI was first reported in farmed Atlantic salmon in Norway in 1999 (Kongtorp et al., 
2004a). Outbreaks of HSMI have been officially recorded in farmed salmon in Norway 
since 2004 and the disease is now widespread in Norwegian salmon aquaculture with 
135 cases recorded in 2015 (Hjeltnes et al., 2016). The disease has also been reported in 
Scotland (Ferguson et al., 2005) and in Ireland (ICES, 2016). The virus was detected, by 
qPCR, in wild Atlantic salmon broodstock and progeny for the first time in Denmark 
in 2014 (ICES, 2016). In 2014, a new disease showing HSMI-like clinical symptoms was 
reported in freshwater farmed rainbow trout in Norway (Olsen et al., 2015). Outside 
Europe, HSMI has been described in farmed Atlantic salmon and coho salmon, O. 
kisutch, in Chile (Godoy et al., 2016). The virus has been detected in farmed Atlantic 
salmon in the Pacific north-west of America and Canada (Siah et al., 2015). 
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2.6.3 Short Description of Clinical Signs  
The disease is most frequently reported in spring and early summer, approximately 6 
months after sea transfer. Morbidity can be high and mortality up to 20%. Gross signs 
include pallor and loose texture of the heart, and pericardial haemorrhage with ascites. 
Haematocrit tends to be normal. Microscopic lesions include myocardial necrosis and 
a severe ventricular myocarditis of both compact and spongy layers with a predomi-
nantly monocytic infiltrate. Coincident epicarditis is common. Lesions occasionally ob-
served include myocarditis of red skeletal muscle, focal necrosis of liver, and oedema 
and congestion in several organs (Kongtorp et al., 2004b). 
2.6.4 Control/preventative measures 
None available. The disease is not listed by the OIE nor under EU Directive 2006/88/EC. 
In 2014 the disease was delisted in Norway (Hjeltnes, 2016). 
2.6.5 Host Species 
HSMI has only been diagnosed in farmed Atlantic salmon. The virus has been detected 
in wild Atlantic salmon and sea trout, Salmo trutta, (Garseth et al., 2013) and in a range 
of marine fish (Wiik-Nielsen et al., 2012a) by qPCR in Norway. The virus has also been 
detected in pacific salmon, namely coho salmon in Chile (Godoy et al., 2016) and coho 
and chinook salmon, O. tshawytscha, on the Pacific coast of America and Canada (Siah 
et al., 2015). 
2.7 Cardiomyopathy Syndrome 
2.7.1 Description of agent 
A novel virus, the piscine myocarditis virus (PMCV) has been proposed as the causa-
tive agent of cardiomyopathy syndrome (CMS). The virus has been detected in fish 
with clinical CMS and has also been localised in the infected tissues (Haugland et al., 
2011). Infection trials have also supported the hypothesis that CMS has a viral aetiology 
(Bruno and Noguera, 2009; Fritsvold et al., 2009). The virus may be present in farmed 
salmon for long periods without any signs of clinical disease (Wiik-Nielsen et al., 
2012b). 
2.7.2 Geographical Distribution and Temporal Trends 
CMS was first diagnosed in Norway in the 1980’s and later in Scotland and the Faroe 
Islands (Brun et al., 2003). A single case of CMS was reported in Ireland with very low 
mortalities in 2012 (Rodger et al., 2014). The number of cases reported in Norway was 
105 in 2015 (Hjeltnes et al., 2016). 
2.7.3 Short description of clinical signs 
Gross signs include haemopericardium (cardiac tamponade) resulting from rupture of 
the atrium or sinus venosus.  Microscopic lesions include myocardial degeneration and 
coagulative necrosis associated with the spongious layer of the ventricle and atrium.  
An infiltrate comprised of lymphocytes and macrophages can be observed. 
2.7.4 Control/Preventative Measures 
None available. The disease is not listed by the OIE nor under EU Directive 2006/88/EC. 
New Trends in Important Diseases Affecting the Culture of Fish 
and Molluscs in the ICES Area 2002 – 2015 |  9 
 
 
2.7.5 Host Species 
CMS has only been diagnosed in farmed Atlantic salmon although the virus has been 
detected by PCR in wild Norwegian Atlantic salmon (Garseth et al., 2012). In Norway, 
a range of wild marine fish species have been screened for PMCV by PCR and only 
samples from the Atlantic argentine, Argentina silus were positive (Böckerman et al., 
2011). 
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3 Bacterial Diseases of Farmed Fish 
3.1 Francisellosis 
3.1.1 Description of Agent 
Bacteria belonging to the genus Francisella are Gram-negative, non-motile, aerobic, fac-
ultative intracellular organisms belonging to the γ-proteobacteria. Most, if not all 
strains isolated from teleost fish belong to either F. noatunensis subsp. orientalis in warm 
water fish species or F. noatunensis subsp. noatunensis in coldwater fish species 
(Colquhoun and Duodu, 2011). Within the ICES area, francisellosis, caused by F. no-
atunensis subsp. noatunensis, has emerged as a major disease in farmed Atlantic cod 
(Ottem et al., 2009).   
3.1.2 Geographical Distribution and Temporal Trends 
Francisellosis was diagnosed for the first time in farmed Atlantic cod in 2004 in Nor-
way (Olsen et al., 2006), however the bacteria (F. noatunensis subsp. noatunensis) have 
also been detected in archived samples of wild-caught cod in the North Sea (Zerihun 
et al., 2011). The bacteria have also been detected by real-time PCR in wild cod along 
the Norwegian coast line (Ottem et al., 2008). There was one reported case of francisel-
losis in Norway in 2014 and none in 2015, down from a peak of 14 in 2008 (Hjeltnes et 
al., 2016). In 2009, the disease occurred in Ireland in a stock of wild-caught cod held in 
captivity as broodstock (Ruane et al., 2015).    
3.1.3 Short description of clinical signs 
Francisellosis is principally a chronic systemic granulomatous inflammatory disease 
with varying degrees of mortality.  The gross signs observed among most host species 
are similar and include disseminated white nodules of various sizes in liver, spleen 
and kidney although most tissues and organs may be affected. Splenomegaly and sero-
sanguinous ascites has been observed in cod.  Microscopic lesions include widespread 
chronic granulomatous inflammation in all organs, associated with variable numbers 
of Gram-negative bacteria (Birkbeck et al., 2011). 
3.1.4 Control/Preventative Measures 
None available. The disease is not listed by the OIE nor under EU Directive 2006/88/EC, 
but is a list 3 disease in Norway. 
3.1.5 Host species 
F. noatunensis subsp. noatunensis has primarily been reported infecting Atlantic cod, 
however there is a single report of francisellosis in Atlantic salmon in Chile (Birkbeck 
et al., 2007). 
3.2 Rainbow Trout Fry Syndrome/Bacterial Coldwater Disease 
3.2.1 Description of Agent 
Flavobacterium psychrophilum is the causative agent of Rainbow Trout Fry Syndrome 
and Bacterial Coldwater Disease. F. psychrophilum is a Gram-negative, slender, flexible 
rod that displays gliding motility. The bacterium requires specific media for isolation 
and growth, e.g. tryptone yeast extract salts agar (Holt et al., 1993). The name “psy-
chrophilum” refers to the low growth optimum of this bacterium, which is around 
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15°C in vitro (Holt et al. 1993) with no growth above 25°C. Other features of this bacte-
rium are its high proteolytic activity as well as its lack of growth in media with > 1% 
salt under laboratory conditions (Dalsgaard and Madsen, 2000).  
3.2.2 Geographical Distribution and Temporal Trends 
F. psychrophilum was originally isolated from diseased juvenile coho salmon in the USA 
in the 1940s (Borg, 1948, 1960), and was first found outside North America during the 
1980s (see Nematollahi et al., 2003), where it appeared in Europe, South America, Japan, 
Korea and Australia. It has for many years been considered an obligate freshwater 
pathogen due to its sensitivity to salt, but there have been reports of disease outbreaks 
with F. psychrophilum in rainbow trout reared in brackish water in Finland (ICES, 2001) 
and spawning bream, Abramis brama, on the Baltic coast of Sweden (ICES, 2013). In 
2008, F. psychrophilum was isolated for the first time in farmed Atlantic salmon in  
Norway, causing septicaemia and mortalities (Nilsen et al., 2011a). The disease has  
regularly caused high mortalities among rainbow trout farmed in the Scandinavian 
countries such as Norway (Nilsen et al., 2011b). Baltic salmon brood fish have been 
shown to be carriers of F. psychrophilum during their spawning migration (Ekman et al. 
1999), and laboratory experiments with water microcosms have shown that the  
bacterium is able to survive salinities up to 0.6‰ (Madetoja et al., 2003). In all, this 
means that F. psychrophilum is able to adapt to more saline environments than origi-
nally expected (Nilsen et al., 2011b).     
3.2.3 Short description of clinical signs 
Disease caused by F. psychrophilum results in septicaemia and/or skin lesions and fin 
rot (Nematollahi et al., 2003). In salmonid fry, the primary sign will be high mortalities 
due to septicaemia, up to 90 % in an affected population, whereas larger fish display 
skin lesions with lower mortalities (Borg, 1960; Holt et al., 1993; Nematollahi et al., 
2003). 
3.2.4 Control/Preventative Measures 
F. psychrophilum disease outbreaks can be treated with antibiotics such as oxytetracy-
cline, amoxicillin, oxolinic acid and florfenicol (Barnes and Brown, 2011), however re-
sistance to antibiotic treatments is becoming an issue (Bruun et al., 2003). There are no 
registered vaccines against the disease at present, therefore prophylactic measures like 
good management procedures (including egg disinfection) as outlined by Madsen and 
Dalsgaard (2008) are recommended. Phage therapy as a potential method for control-
ling F. psychrophilum infections is also being investigated (Madsen et al., 2013). 
3.2.5 Host species 
Juvenile rainbow trout and coho salmon are particularly susceptible (Nematollahi et 
al., 2003). However, F. psychrophilum infections have been reported in a wide range of 
both anadromous and non-anadromous salmonids of various sizes. In addition, F. psy-
chrophilum has either caused disease or been detected in Japanese eel Anguilla japonica, 
European eel Anguilla anguilla, common carp Cyrpinus carpio, crucian carp Carassius 
carassius, tench Tinca tinca, ayu Plecoglossus altivelis, pale chub Zaco platypus, perch Perca 
fluviatilis and roach Rutilis rutilis (Barnes and Brown, 2011). 
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3.3 Enteric Redmouth Disease 
3.3.1 Description of Agent 
The aetiological agent of enteric redmouth disease (ERM) is Yersinia ruckeri, a gram 
negative, slightly curved, rod shaped bacteria. Most of the bacteria are motile due to 
the presence of flagellae (Barnes, 2011). Strains of Y. ruckeri can be classified on the 
basis of biotype, serotype and outer-membrane protein (OMP) type (Tobback et al., 
2007) however a combination of these is useful for discriminating between strains (Da-
vies, 1991; Wheeler et al., 2009). The most common Y. ruckeri serovar is O1, with the 
most virulent being the O1a serotype Hagerman strain (Davies, 1991). Serovar O1 
Y.ruckeri grow well on tryptone soya agar with or without 5% blood. After a 48 h incu-
bation at 20-25°C, round, raised, shiny off-white colonies of 2-3 mm in diameter de-
velop (Austin and Austin, 2007). Over the last decade, a new biotype 2 strain has 
emerged causing mortalities in Europe (Wheeler et al., 2009). There were 34 confirmed 
sites affected by ERM in Norway in 2015 (Hjeltnes et al., 2016). 
3.3.2 Geographical Distribution and Temporal Trends 
ERM was first described in the USA in 1955 and became widespread in farmed salm-
onid species throughout the USA and Canada (Furones et al., 1993). The disease is now 
present throughout Europe, Australia, Chile and South Africa (Barnes, 2011). The most 
probable route of spread has been by horizontal transmission through the import of 
live fish and ova. In recent years, Biotype 2 strains have emerged causing significant 
losses in rainbow trout facilities in the UK (Austin et al., 2003), Spain (Fouz et al., 2006), 
USA (Arias et al., 2007) and Finland (ICES, 2012).  
3.3.3 Short description of clinical signs  
ERM can affect fish of all ages, but is most acute in juveniles, while in larger fish the 
disease appears as a more chronic condition. The characteristic haemorrhages around 
the oral cavity led to the name ‘redmouth’ disease, although this is often not apparent 
in many cases of disease (Tobback et al., 2007). The disease is mainly seen as a general-
ised haemorrhagic septicaemia with anorexia, darkening of the skin, haemorrhages in 
the skin, gills and at the base of the fins and the lateral line. Bleeding is also common 
in internal organs; swimbladder, liver, spleen, pancreas and visceral fat in connection 
with the pyloric caecae. Kidney and spleen are swollen and darkened in colour (Rob-
erts, 2012; Barnes, 2011). McArdle (2014) recently reported that heart pathology was a 
consistent finding in outbreaks in Ireland over a number of years and may explain the 
behavioural changes of diseased fish. 
3.3.4 Control/Preventative Measures 
ERM has successfully been controlled by the use of a monovalent vaccine based on a 
Hagerman type strain, biotype 1. Following reports of vaccine failures, connected to 
new strains classified as biotype 2, new vaccines contain antigens from both the Hager-
man type strain and Biotype 2 (Deshmuk et al., 2012). This vaccine offers good protec-
tion when administered by intra-peritoneal injection supplemented with an additional 
booster by immersion (Chettri et al., 2013). Antibiotics also play a role in controlling 
infection as Y. ruckeri is sensitive to a range of antibiotics (e.g. oxytetracycline, oxolinic 
acid and potentiated sulphonamides), however there are increasing reports of antibi-
otic resistance (Tobback et al., 2007). 
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3.3.5 Host species 
ERM is primarily a disease infecting salmonid fish species, particularly rainbow trout. 
The agent has also been isolated from a wide range of non-salmonid fish species, 
though not all exhibited pathology related to infection with Y. ruckeri (Furones et al., 
1993).  
3.4 Red Spot Disease/Pseudomoniasis 
3.4.1 Description of Agent 
Pseudomona anguilliseptica, a Gram-negative motile rod, is an opportunistic pathogen 
for a variety of fish species cultured in marine and brackish waters worldwide. It is the 
aetiological agent of ‘red spot disease’ also known as ‘Sekiten-byo’ disease of eels. The 
bacteria can be isolated from blood, kidney, liver and spleen samples on a nutrient 
agar, supplemented with 10% blood. The bacteria are quite slow growing and incuba-
tion at 20-25°C should continue for at least 7 days, when round, raised, shiny, pale-
grey colonies, less than 1 mm in diameter develop (Wakabashi and Egusa, 1972). Sero-
logically, two major groups have been established on the basis of their O-antigens with 
serotype O2 including the majority of eel isolates and serotype O1 including isolates 
from all other fish species (Lopez-Romalde et al., 2003). 
3.4.2 Geographical Distribution and Temporal Trends  
P. anguilliseptica has been reported from Japan and Taiwan (Wakabayashi and Egusa, 
1972; Nakai et al., 1985), Kuwait (Al-Marzouk, 1999) and in a number of European 
countries such as Scotland, Finland, France, Spain and The Netherlands (Stewart et al., 
1983; Wiklund and Bylund, 1990; Berthe et al., 1995; Domenech et al., 1999; Haenan and 
Davidse, 2001). In Finland, P. anguilliseptica has become a significant cause of disease 
outbreaks in rainbow trout reared in brackish water during extremely warm summers 
when water temperatures rise above 20°C and rearing conditions are poor (ICES, 2012).  
3.4.3 Short description of clinical signs  
Diseased fish have pethechial haemorrhage of the skin, peritoneum and liver. Kidney 
can have liquefactive necrosis (Wakabashi and Egusa, 1972; Ellis et al., 1983; Wiklund 
and Bylund, 1990). Diseased rainbow trout in Finnish brackish water farms appear 
dark in colour, with a sluggish appearance and large hyperaemic and odematic areas 
are observed on the sides of the fish. 
3.4.4 Control/Preventative Measures 
In Finland P. anguilliseptica infections in rainbow trout have successfully been treated 
with Sulfa-Trimetoprim (30 mg/Kg for 7 days) in combination with improve hus-
bandry on the farms. There is no comercial vaccine available in Europe.  
3.4.5 Host species 
P. anguilliseptica was first described as red spot disease of Japanese eels (Wakabashi 
and Egusa, 1972). Since then, the pathogen has been recorded in a range of fish species 
including European eel, (Stewart et al., 1983), rainbow trout, sea trout, white fish Core-
gonus sp., Baltic herring, Clupea harengus membras (Wiklund and Lönnström, 1994; Lö-
nnström et al., 1994), sea bass, Dicentrarchus labrax (Berthe et al., 1995), Gilthead sea 
bream, Sparus aurata (Domenech et al., 1999), orange-spotted grouper, Epinephelus coi-
oides (Al-Marzouk, 1999), Atlantic cod, (Ferguson et al., 2004) and turbot (Magi et al., 
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2009). P. anguilliseptica has also been isolated from lumpsucker (Cyclopterus lumpus) 
used as cleaner fish on Atlantic salmon farms in Norway (Hjeltnes et al., 2016). 
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4 Parasitic Diseases of Farmed Fish 
4.1 Amoebic Gill Disease 
4.1.1 Description of Agent 
AGD was initially ascribed to Neoparamoeba pemaquidensis, based on morphological 
(Dyková at al., 2000) and molecular characterisation (Wong et al., 2004). The isolation 
of N. branchiphila from AGD-affected fish (Dyková et al., 2005) meant that the disease 
may have a mixed aetiology. However, issues still remained with the development of 
a reproducible experimental challenge model using both species (Morrison et al., 2004; 
Vincent et al., 2007). Using molecular techniques, Young et al. (2008) showed that N. 
perurans was the aetiological agent of AGD which was subsequently confirmed by la-
boratory trials and fulfilment of Koch’s Postulates (Crosbie et al., 2012).  
4.1.2 Short Description of Clinical Signs 
AGD is characterised by multifocal lesions that appear as pale gill tissue, or white mu-
coid spots and plaques. The main histological feature of the disease is prominent epi-
thelial hyperplasia resulting in a complete lamellar fusion. Large mucous cells are often 
situated on the surface of the hyperplastic epithelium and between the lamellae, with 
significant leucocyte infiltration (Mitchell and Rodger, 2011). 
4.1.3 Geographical Distribution and Temporal Trends 
The disease has long been associated with farmed Atlantic salmon in Tasmania (Mun-
day et al., 1993) and has also been reported in farmed Atlantic salmon in Ireland 
(Palmer et al., 1997), Scotland, Norway (Steinum et al., 2008) and Chile (Bustos et al., 
2011). The disease has also been reported in the Mediterranean (Dyková et al., 2000; 
Munday et al., 2001) and in South Africa (Mouton et al., 2014). The disease re-emerged 
in Ireland and Scotland in 2012 and in Norway and the Faroe Islands in 2014 (Rodger, 
2014; Oldham et al., 2016). AGD has also been reported in Canada (ICES, 2016). 
4.1.4 Control/Preventative Measures 
The recommended treatment for AGD is a 2 – 3 h freshwater bath (Clark et al., 2003). 
Treatment with hydrogen peroxide has also shown to be effective (Adams et al., 2012). 
Regular screening of the gills through gill scoring (Taylor et al., 2009) and non-lethal 
sampling for molecular diagnostics (Downes et al., 2017) have proven useful for disease 
monitoring. AGD is not a notifiable disease. 
4.1.5 Host Species 
Amoebic Gill Disease (AGD) primarily affects salmonids and was first described in 
marine reared coho salmon (S. kisutch) in Washington and California, USA (Kent et al., 
1988) and in Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss) in 
Tasmania (Munday et al., 1993). However, the disease has also been reported in turbot, 
Psetta maxima and sea bass Dicentrarchus labrax (Munday et al., 2001) and has recently 
been described in ballan wrasse, Labrus bergylta (Karlsbakk et al., 2013) and lumpsucker 
(Hjeltnes et al., 2016). 
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5 Viral Diseases in Farmed Molluscs 
5.1 Ostreid herpesvirus 1 in bivalves 
5.1.1 Description of Agent 
Ostreid herpesvirus 1 (OsHV-1) is the aetiological agent of a contagious viral disease 
affecting bivalve species including the Pacific oyster, Crassostrea gigas. OsHV-1 parti-
cles have been purified from French C. gigas larvae (Le Deuff and Renault, 1999) and 
were observed by transmission electron microscopy to be enveloped icosahedral with 
electron dense cores and a diameter around 120 nm. The entire virus DNA was se-
quenced and OsHV-1 capsids appear structurally similar to those of other herpesvi-
ruses that have been studied (Davison et al., 2005). The virus was classified under the 
name Ostreid herpesvirus 1 (OsHV-1) as the first known species in the family Malaco-
herpesviridae, order Herpesvirales. 
Although the aetiological agent is represented by all specimens of OsHV-1 (Arzul et 
al., 2001; Davison et al., 2005; Moss et al., 2007; Segarra et al.; 2010, Martenot et al., 2011; 
Renault et al., 2012), increased mortality outbreaks recently reported in Europe, Aus-
tralia and New Zealand among C. gigas spat in association with all OsHV-1 µVar viral 
variants suggest differences in terms of virulence among OsHV-1 lineages. However, 
the detection of variants related to OsHV-1 µVar have also been reported in the absence 
of mortality events (Dundon et al., 2011; Shimahara et al., 2012) suggesting the involve-
ment of several factors in disease expression. 
5.1.2 Geographical Distribution and Temporal Trends 
OsHV-1 representatives have been reported in Europe (France, Ireland, Italy, the Neth-
erlands, Spain, Sweden, United Kingdom), Australia, Brazil, China (People’s Rep. of), 
Korea, Japan, Morocco, Tunisia, Mexico, New Zealand and the United States of Amer-
ica. 
Since 2008, widespread mortality was reported among C. gigas stocks in different Mem-
ber States of the European Union in association with emergence of the hypervirulent 
OSHV-1 Var variant (Segarra et al., 2010; Peeler et al., 2012; Roque et al., 2012). The 
outbreaks are seasonal and highly temperature dependent with mortality rates of up 
to 100% (Clegg et al., 2014). Mortality events attributed to OsHV-1 Var  variants were 
also reported beginning in 2010 in Australia and New Zealand (Jenkins et al., 2013).  
5.1.3 Short Description of Clinical Signs  
The virus can be found in adult bivalves in the absence of mortality. Infection-associ-
ated lesions in juveniles are mainly observed in connective tissues of all organs in 
which fibroblastic-like cells exhibit enlarged nuclei with perinuclear chromatin (Re-
nault et al.; 1994; Schikorski et al., 2011). 
5.1.4 Control/Preventative Measures 
The herpes infection affecting bivalves is not listed by the World Organisation for An-
imal for Animal Health (WOAH) (OIE) and the EU (Directive 2006/88/EC). Pacific 
cupped oyster families less susceptible to OsHV-1 including the variant OsHV-1 µVar 
can be produced for aquaculture use (Sauvage et al., 2009). Biosecurity may be success-
fully applied in confined and controlled facilities such as hatcheries and nurseries in 
order to protect the facility and the surrounding environment from the introduction of 
the virus. 
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5.1.5 Host Species 
OsHV-1 infection causes mortality in larvae and juveniles of several bivalve species 
(Renault et al., 1994; Garcia et al., 2011) including the Pacific oyster, C. gigas, Portuguese 
oyster, Crassostrea angulata, suminoe oyster, Crassostrea ariakensis, European flat oyster, 
Ostrea edulis, Manila clam, Ruditapes philippinarum, carpet shell clam, Ruditapes decus-
satus, and great scallop, Pecten maximus. However, the variant µVar (Segarra et al., 2010) 
primarily infects C. gigas.  
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6 Bacterial Diseases of Farmed Molluscs 
6.1 Vibrio sp. infecting marine molluscs 
6.1.1 Vibrio splendidus infecting Pacific oysters 
6.1.1.1 Description of Agent 
Gram-negative bacteria related to Vibrio splendidus are frequently found in coastal areas 
and can infect and induce mortalities in the Pacific oyster, C. gigas (Lacoste et al., 2001; 
Samain et al., 2004; Saulnier et al., 2010). Through epidemiological studies a high genetic 
diversity was observed in this group suggesting that the splendidus clade is diverse and 
possibly polyspecific (Le Roux et al., 2002). 
6.1.1.2 Geographical Distribution and Temporal Trends 
Since 2008, widespread mortality events have been reported among C. gigas in France. 
The outbreaks are seasonal and most frequently affect spat and juveniles (< 18 months). 
Mortality rates of 40-100% were experienced. While the mortality in young oysters has 
generally been attributed to emergence of the OsHV-1 µVar (EFSA, 2010; Segarra et al., 
2010), V. splendidus was frequently detected in affected, as well as unaffected, oysters 
(EFSA, 2010). 
6.1.1.3 Short Description of Clinical Signs 
The main sign of V. splendidus infections in the Pacific oyster remains reports of mor-
tality events (Saulnier et al., 2010). There are no reliable clinical indicators of V. splen-
didus infection in oysters. 
6.1.1.4   Control/Preventative Measures 
V. splendidus infection is not listed by the World Organisation for Animal Health 
(WOAH) and the EU (Directive 2006/88/EC). 
6.1.1.5    Host species 
V. splendidus-related species were reported in association with mortality outbreaks af-
fecting different mollusc species (Sugumar et al., 1998; Macian et al., 2000; Lacoste et al., 
2001; Gay et al., 2003; Gay et al., 2004). 
6.1.2 Vibrio aestuarianus infecting oysters 
6.1.2.1 Description of Agent 
The gram-negative bacterium Vibrio aestuarianus is frequently found in coastal areas 
and can infect and induce mortality outbreaks among the Pacific oyster, C. gigas (Sa-
main et al., 2004; Garnier et al., 2008; Saulnier et al., 2010). 
6.1.2.2 Geographical Distribution and Temporal Trends 
V. aestuarianus has been reported to be associated with mortality of oyster reared in 
open marine waters in France. Some bacterial isolates related to this species were 
demonstrated to be pathogenic to C. gigas under experimental conditions (Garnier et 
al., 2007; Azandegbe et al., 2010). 
6.1.2.3 Short Description of Clinical Signs 
V. aestuarianus has frequently been among the pathogens associated with massive mor-
tality events occurring during summer in C. gigas oysters. These events often occur 
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when seawater temperatures reach 19°C on the French Atlantic coast (Garnier et al., 
2007; Labreuche et al., 2010). Classic bacteriology studies revealed that moribund ani-
mals were predominantly infected with V. aestuarianus, found in the hemolymph but 
also in other oyster tissues (Azandegbe et al., 2010). 
6.1.2.4 Control/Preventative Measures 
V. aestuarianus infection is not listed by the World Organisation for Animal Health 
(WOAH) or the EU (Directive 2006/88/EC). 
6.1.2.5    Host species 
The gram-negative bacterium V. aestuarianus is mainly reported infecting the C. gigas. 
However, V. aestuarianus has also been recently detected in the cockle Cerastoderma 
edule in France in association with mortality outbreaks (C. Garcia et al., IFREMER, pers. 
comm.). 
6.1.3 Vibrio harveyi in abalone 
6.1.3.1 Description of Agent 
The gram-negative bacterium Vibrio harveyi is known to be highly pathogenic for the 
European abalone Haliotis tuberculata. Since 1998, specific strains of V. harveyi have been 
implicated in mortality outbreaks in French farms and field stocks of abalone (Nicolas 
et al., 2002). V. harveyi has been widely recognized as a common pathogen of many 
commercially cultured fish and shellfish species worldwide (Gomez et al., 2004) includ-
ing abalone in Australia and Japan (Nishimori et al., 1998; Handlinger et al., 2005; 
Sawabe et al., 2007). 
6.1.3.2    Geographical Distribution and Temporal Trends 
The bacterium has been involved in recurrent mortality outbreaks occurring season-
ally, at the end of warm season, since 1998 in farms and field stocks of H. tuberculata in 
France (Nicolas et al., 2002).  
6.1.3.3 Short Description of Clinical Signs  
Although non-specific, clinical signs of V. harveyi infection include a loss of muscular 
strength occurring concomitantly with the appearance of white pustules on the foot. 
Subsequently, diseased animals develop a fatal septicemia leading to up to 80% mor-
tality within a few days to 3 weeks. Vibriosis outbreaks in H. tuberculata cultivated in 
France were shown to be driven by seawater temperature exceeding a 17°C threshold 
(Huchette and Clavier, 2004) and host physiology such as gametogenesis and reduced 
immune defense capacities (Travers et al., 2008). 
6.1.3.4    Control/Preventative Measures 
V. harveyi infection is not listed by the World Organisation for Animal Health (WOAH) 
(OIE, 2012) and the EU (Directive 2006/88/EC). 
6.1.3.5    Host species 
Vibrio harveyi infects members of the genus Haliotis, but has been also reported in bi-
valve molluscs (Saulnier et al., 2010). 
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6.2 Nocardia crassostreae in oysters 
6.2.1 Description of Agent 
Nocardia crassostreae, a gram-positive actinomycete, is the causative agent of Pacific 
Oyster Nocardiosis (PON). The cycle of N. crassostreae in the environment between oys-
ters is unknown. As most Nocardia species are soil bacteria this may suggest that N. 
crassostreae is acquired from the environment as an opportunistic invader of live oys-
ters (Bower et al., 2005). The soil substrate could be a natural source of N. crassostreae. 
6.2.2 Geographical Distribution and Temporal Trends 
The disease has been reported since the late 1940s in Japan and the west coast of North 
America in association with C. gigas field mortality outbreaks (Friedman et al., 1991; 
Bower et al., 2005). The extent of associated mortalities has not been accurately meas-
ured but estimated at about 35% in some localities. In British Columbia (Canada), Eu-
ropean flat oysters O. edulis cultured alongside infected C. gigas have been found in-
fected by N. crassostreae but mortality rate is unknown. 
Over the last decade, the geographical distribution of N. crassostreae has extended out-
side the North Pacific with the report of N. crassostreae in C. gigas from the Netherlands 
(Engelsma et al., 2008) and in Mytilus galloprovincialis and O. edulis from Italy (Carella 
et al., 2013). 
6.2.3 Short Description of Clinical Signs  
The bacterium can be found all year as bacterial foci primarily in gonad follicles, vesic-
ular connective tissue, gills, heart and adductor muscle, but they can invade every tis-
sue. Bacteria are usually associated with mortalities during the late summer and fall. 
C. gigas oysters experimentally infected showed clinical signs and mortality (Friedman 
et al., 1991; Friedman et al., 1998). 
6.2.4 Control/Preventative Measures 
N. crassostreae infection is not listed by the World Organisation for Animal Health (OIE) 
or the EU (Directive 2006/88/EC). Bottom culture of oysters may possibly expose oys-
ters more to N. crassostreae than other types of culture and so may be avoided to poten-
tially mitigate infection pressure where it is intense. 
6.2.5 Host species 
N. crassostreae causes infection in the oysters C.  gigas and O. edulis and was recently 
described in the mussel M. galloprovincialis (Carella et al., 2013). 
6.3 Candidatus xenohaliotis californiensis in abalone 
6.3.1 Description of Agent 
Candidatus xenohaliotis californiensis is an intracellular bacterium (332 × 1550 nm in 
the bacillus form and an average of 1405 nm in the spherical morphotype) in the family 
Anaplasmataceae and is closely related to members of the genera Ehrlichia, Anaplasma 
and Cowdria (Friedman et al., 2000). Infection has been reported in wild and farmed 
abalone, Haliotis spp. (Archeogastropoda: Mollusca) (Gardner et al., 1995; Friedman et 
al., 2000). The disease caused by this bacterium is known as withering syndrome and 
may be more appropriately termed abalone rickettsiosis. 
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6.3.2 Geographical Distribution and Temporal Trends 
Candidatus xenohaliotis californiensis accurs along the south-west coast of Noth Amer-
ica in California, USA and Baja California, Mexico. However, as infected abalone have 
been transported to Chile, Japan, Israel, Iceland and possibly other countries, a large 
geographical distribution of the bacterium is suspected. Infections have resulted in se-
vere economic impacts to abalone culturists along the west coast of North America. 
Reduced profits have been associated with farm closures as well as contributing to the 
closure of commercial fisheries in California. Moreover, recurring disease outbreaks 
are also implicated in failure of wild abalone to repopulate historic habitats (Friedman 
and Finley, 2003). Candidatus xenohaliotis californiensis has now been detected in Eu-
rope including Ireland, Spain and France in the European abalone, H. tuberculata 
(Balseiro et al., 2006). 
6.3.3 Short Description of Clinical Signs 
Clinical disease is typically observed in abalone over 12 months of age. Clinical disease 
has only been observed in infected individuals exposed to elevated seawater tempera-
tures (e.g. 18°C). Gross signs of the infection include pedal atrophy, mottled digestive 
gland, anorexia, weakness, and lethargy before death. Associated losses may reach 99% 
of the population and depending on seawater temperatures and host species. 
6.3.4 Control/Preventative Measures 
The most effective prevention is avoidance of the pathogen. Infection caused by Candi-
datus xenohaliotis californiensis in molluscs is not listed as a notifiable disease under 
EU legislation (Directive 2006/88/EC). Infection is however included in the Manual of 
Diagnostic Tests for Aquatic Animals (www.oie.int) and an OIE Reference Laboratory 
for this pathogen has been designated. Should infection occur, holding abalone at tem-
peratures below 15°C may reduce pathogen transmission and subsequent disease de-
velopment. Application of oxytetracycline reduces losses. 
6.3.5 Host species 
Candidatus xenohaliotis californiensis infects members of the genus Haliotis and natural 
infections have been observed in black abalone (H. cracherodii), white abalone (H. 
sorenseni), red abalone (H. rufescens), pink abalone (H. corrugata), green abalone (H. ful-
gens), the small abalone (H. diversicolor supertexta), and the European abalone (H. tuber-
culata) in the wild or in culture facilities, as well as flat (H. wallalensis) and Japanese 
abalone (H. discus-hannai) in laboratory challenges. Other abalone species have not 
been tested. 
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7 Diseases of Mollusc: Parasitic Diseases 
7.1 Bonamia exitiosa 
7.1.1 Description of Agent 
Bonamia exitiosa is a protozoan parasite in the Haplosporida, phylum Cercozoa (Cava-
lier-Smith and Chao, 2003), infecting haemocytes of several oyster species and induc-
ing physiological disorders and eventually death of the animal (Dinamani et al., 1987; 
Cranfield et al., 2005). It is an intrahaemocytic protozoan, but it can be observed extra-
cellularly (Dinamani et al., 1987). This intrahaemocytic protozoan quickly becomes sys-
temic and can be found in different organs, especially in connective tissues (Hine, 
1991). 
7.1.2 Geographical Distribution and Temporal Trends 
Infection with B. exitiosa is found in oyster Ostrea chilensis in the Foveaux Strait and 
other locations around South Island, New Zealand (Dinamani et al., 1987); and in Ostrea 
angasi and Saccostrea glomerata in New South Wales, Victoria, Tasmania, and Western 
Australia ( Hine and Jones, 1994; Hine, 1996; Corbeil et al., 2006; Carnegie et al., 2014). 
More recently, infection with B. exitiosa was reported in O. edulis in Galicia (Spain) 
(Abollo et al., 2008), in the Adriatic Sea in Italy (Narcisi et al., 2010), in the Mediterra-
nean Sea in France and in Cornwall in the United Kingdom as well as in Ostrea stentina 
in Tunisia (Hill et al., 2010). Molecular analyses have confirmed the presence of the 
parasite in the Americas as well, infecting O. stentina (= Ostreola equestris) along the 
southeastern Atlantic coast of the USA, Ostrea lurida in California, USA, and Ostrea 
puelchana in Argentina (Hill et al., 2014). 
7.1.3 Short Description of Clinical Signs  
Infection can be lethal. In O. chilensis, death usually occurs as infections peak in inten-
sity, particularly in association with high intensity apicomplexan infections (Hine and 
Wesney, 1994; Hine et al., 2002). In one episode the disease killed more than 80% of O. 
chilensis as a wave of infection passed through an oyster bed over 2–3 years (Cranfield 
et al., 2005). The impact of B. exitiosa in O. edulis or O. stentina has not yet been evalu-
ated. 
In O. angasi, the parasite is epitheliotropic, and apparently very light infections may 
cause a massive focal haemocyte infiltration with necrotic foci. In O. edulis, the parasite 
is associated with heavy haemocytic infiltration and appears in the connective tissue 
of different organs mostly within haemocytes, but sometimes outside host cells (Abollo 
et al., 2008). In O. stentina, marked haemocytosis was not observed in animals found to 
be infected with the parasite (Hill et al., 2010). 
7.1.4 Control/Preventative Measures 
Infection caused by B. exitiosa in molluscs is listed as a notifiable disease by the EU 
legislation (Directive 2006/88/EC). The infection is also listed by the OIE and included 
in the Manual of Diagnostic Tests for Aquatic Animals (www.oie.int). 
It has been considered that in New Zealand development of lighter dredges and less 
damaging fishing strategies may reduce the chance of disease outbreaks by lowering 
disturbance (Cranfield et al., 2005). Avoiding stressors such as exposure to extreme 
temperatures (below 7 or above 26°C) and salinity (40%), starvation, handling, or 
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heavy infection with other parasites, as well as decreasing density, should help to re-
duce the impact of the disease in that system (Cranfield et al., 2005; Hine et al., 2002). 
Control elsewhere should focus on preventing the introduction of B. exitiosa to areas in 
which it has not yet become established. 
7.1.5 Host species 
Oyster species O. chilensis (= Tiostrea chilensis = T. lutaria) (Dinamani et al., 1987), O. 
angasi (Hine and Jones, 1994; Hine, 1996; Corbeil et al., 2006), O. edulis (Abollo et al., 
2008; Narcisi et al., 2010), O. stentina (Hill et al., 2010) and O. puelchana, O. lurida, and S. 
glomerata (Hill et al., 2014). 
7.2 Bonamia ostreae 
7.2.1 Description of Agent 
Bonamia ostreae is a protozoan parasite in the Haplosporida (Pichot et al., 1979; Comps 
et al., 1980; Carnegie et al., 2000), phylum Cercozoa (Cavalier-Smith and Chao, 2003), 
infecting haemocytes of flat oysters, O. edulis, and inducing physiological disorders 
and eventually death of the animal (Grizel, 1985). It is an intrahaemocytic protozoan, 
but it can be observed extracellularly.  
7.2.2 Geographical Distribution and Temporal Trends 
Infection with B. ostreae has been found in Europe (France, Ireland, Italy, The Nether-
lands, Portugal, Spain and the United Kingdom), Canada (British Columbia), the 
United States of America (California, Maine and Washington states), and New Zealand 
(Lane et al., 2016). The parasite was also reported for the first time in flat oysters in 
Denmark in 2014 (ICES, 2015). 
7.2.3 Short Description of Clinical Signs  
B. ostreae is an intrahaemocytic protozoan but it can be observed extracellularly be-
tween epithelial or interstitial cells in the gills and stomach or in necrotic connective 
tissue areas. Intraepithelial localisation has also been reported in gills (Montes et al., 
1994) and the parasite has been reported in ovarian tissue (Van Banning, 1990). Ad-
vanced infections can become systemic. O. edulis of a year or less in age can develop a 
high prevalence and intensity of infection with associated mortality within six months 
of exposure to B. ostreae (Lynch et al., 2005). However, individuals older than two years 
appear to be more susceptible to the disease (Culloty and Mulcahy, 1996; Grizel, 1985; 
Engelsma et al., 2010). Seed from natural settlements appear to be significantly more 
parasitised than oyster seed from hatcheries (Conchas et al., 2003). Infection of wild and 
cultured flat oysters is often lethal, and death usually occurs concurrently with the 
highest intensity infection level.  
7.2.4 Control/Preventative Measures 
Infection caused by B. ostreae in molluscs is listed as a notifiable disease under EU leg-
islation (Directive 2006/88/EC) and also by the OIE (www.oie.int). Mortalities caused 
by bonamiosis can be reduced using suspension culture, lower stocking densities or by 
culturing O. edulis with C. gigas, which is far less susceptible to infection. Oyster seed 
from hatcheries are preferred for aquaculture use over seed from natural settlements 
as the latter appear to be significantly more parasitised (Conchas et al., 2003). Resistant 
strains of O. edulis developed through selective breeding may offer an alternative in 
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infected areas. Selective breeding has been shown to be effective in reducing suscepti-
bility and mortality caused by B. ostreae (Naciri-Graven et al., 1998). 
7.2.5  Host species 
O. edulis is the only known species that is significantly naturally susceptible to B. os-
treae, C. gigas being only scarcely susceptible at most (Lynch et al., 2010).  Infection in-
tensity increases concurrently to mortality with age and/or size of the oysters (Culloty 
and Mulcahy, 1996; Grizel, 1985).  
7.3 Marteiliosis 
7.3.1 Description of Agent 
Marteiliosis is a disease of marine bivalve molluscs caused by protozoan parasites in 
the genus Marteilia (order Paramyxida, phylum Cercozoa; Cavalier-Smith and Chao, 
2003), including M. refringens, M. sydneyi, M. chungmuensis, M. cochillia among other 
described species. Marteilia species display a cell-within-a-cell structure in which trice-
llular spores are produced; the pattern of secondary cells produced within primary 
cells and tricellular spores within secondary cells distinguishes individual Marteilia 
species (Feist et al., 2009). Sporulation occurs extracellularly within digestive tubule 
epithelia in M. refringens (Herrbach, 1971), M. sydneyi (Wolf, 1972), and M. cochillia (Ca-
rrasco et al., 2011), but within oocytes in Asian M. chungmuensis (Comps et al., 1986).  
7.3.2 Geographical Distribution and Temporal Trends 
M. refringens occurs from France southward along the Atlantic coast of Europe as well 
as in the Mediterranean Sea at least as far east as Greece, and in Tunisia (Virvilis and 
Angelidis, 2003; Carrasco et al., 2007; Elgharsalli et al., 2013; Arzul et al., 2014). It contri-
buted to the decline of O. edulis oyster populations and remains an economically signi-
ficant pathogen of flat oysters and mussels. Reports over the last decade have noted 
the occurrence of M. refringens in Sweden (ICES 2010, 2011) and southern England 
(ICES 2012). M. cochillia was discovered in the context of significant cockle (C. edule) 
mortality in the Ebro Delta of Mediterranean Spain in 2008 (Carrasco et al., 2011), and 
was associated with cockle mortality that approached 100% in the Ría de Arousa of the 
Atlantic coast of Spain in 2012 (Villalba et al., 2014). It represents a notable new threat 
to an important European fishery species. M. sydneyi and M. chungmuensis are econo-
mically significant pathogens but remain absent from the ICES area, M. sydneyi occu-
rring in eastern Australia (Wolf, 1979) and M. chungmuensis in Korea and Japan (Comps 
et al., 1986; Itoh et al., 2002).  
7.3.3 Short Description of Clinical Signs 
Marteilia parasites sporulating in host digestive tubule epithelia migrate to that tissue 
from portals of entry elsewere, primarily the epithelia of palps or stomach in the case 
of M. refringens (Grizel, 1974; Berthe et al., 2004). Infections can be difficult to detect 
before colonization of the digestive tubules, but parasite proliferation afterward pro-
duces sharp increases in infection intensity and marked disruption to digestive tubule 
structure and function, with emaciation of the host and significant mortality a common 
result (Figueras and Montes, 1988; Villalba et al., 1993). Gonadal infection by M. 
chungmuensis produces gross nodular lesions in affected Pacific oysters (Bower et al., 
2011).  
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7.3.4 Control/Preventative Measures 
Infection with M. refringens is a disease listed by both the World Organisation for Ani-
mal Health (OIE) and the EU (Directive 2006/88/EC). It is on the US National List of 
Reportable Animal Diseases and on Canada’s list of Federally Reportable Aquatic Ani-
mal Diseases - Molluscs. Infection with M. chungmuensis is also on the Canadian list, 
and infection with M. chungmuensis and infection with M. sydneyi are both under re-
view for US listing. Infection with M. cochillia is not listed. As M. refringens primarily is 
a pathogen of warmer estuarine systems, parasite impacts may be minimized by cul-
turing susceptible hosts in higher salinity outer coastal waters and in cooler areas, the 
parasite requiring temperatures of 17°C or greater to infect oyster hosts (Berthe et al., 
2004). M. refringens is known to infect copepods Paracartia grani (Audemard et al., 2001, 
2002) and P. latisetosa (Arzul et al., 2014) in addition to its molluscan hosts, but limited 
understanding of its presumably indirect life cycle otherwise limits options for its con-
trol. 
7.3.5 Host Species 
M. refringens primarily infects oyster O. edulis and mussels M. edulis and M. gallopro-
vincialis, though numerous other molluscs have been proven to be hosts, and there is 
molecular evidence suggestive of infection in others (www.oie.int). Vigorous debate 
continues about whether M. refringens infecting mussels represents a distinct species, 
M. maurini (Comps et al., 1982). Two distinct genetic lineages of M. refringens exist, with 
parasites on one more likely to infect oysters and parasites on the other to infect mus-
sels (LeRoux et al., 2001; López-Flores et al., 2004, Novoa et al., 2005). While the diver-
gence of these parasite lineages may reasonably be interpreted as a speciation event, 
imperfect fidelity to host type among the parasites on the two lineages would argue 
that they should conservatively be regarded as a single species, M. refringens, for most 
effective health management. 
M. cochillia infects cockle C. edule (Carrasco et al., 2013), M. sydneyi infects the Sydney 
rock oyster S. glomerata (Perkins and Wolf, 1976), and M. chungmuensis infects the Pa-
cific oyster C. gigas (Comps et al., 1986), and possibly suminoe oyster C. ariakensis and 
Manila clam R. philippinarum (Yanin et al., 2013). 
7.4 Haplosporidiosis 
7.4.1 Description of Agent 
Haplosporidiosis is caused by protozoan parasites in the Haplosporida, phylum Cer-
cozoa (Cavalier-Smith and Chao, 2003). Members of two genera, Haplosporidium and 
Minchinia, are responsible for haplosporidiosis in various molluscs. The parasites pre-
sent uni- and binucleate cells and plasmodia of varying nuclear counts, in addition to 
sporogonic forms, with spore structure being used to assign parasites to genus (Burre-
son and Ford, 2004; Burreson and Reece, 2006). All are believed to be indirectly trans-
missible through intermediate hosts, none of which have ever been identified. Mollusc 
pathogens causing haplosporidiosis in the region include H. nelsoni, H. costale, H. armo-
ricanum, H. edule, and M. tapetis. 
7.4.2 Geographical Distribution and Temporal Trends 
H. nelsoni is the most significant agent of haplosporidiosis. It is native to Pacific oyster 
C. gigas populations in Asia (Burreson et al., 2000), and is associated with established 
C. gigas populations in other parts of the world, including Europe (Renault et al. 2000, 
Lynch et al., 2013) and western Canada (ICES, 2008), though without causing much 
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disease. It has been far more pathogenic in eastern oyster C. virginica along the Atlantic 
coast of North America, however, where it ranges from Florida to Maine, USA (Ford, 
1996) and occurs also in Nova Scotia, Canada. The most significant H. nelsoni impacts 
in recent years have been in the northern part of its distribution, with major epizootics 
in Nova Scotia begining in 2002 (ICES, 2003) and in Maine in 2010. In the Chesapeake 
and Delaware Bays of the Mid-Atlantic coast of the USA, however, H. nelsoni impacts 
have been declining with increasing disease resistance in the oyster host (Carnegie and 
Burreson, 2011; Ford and Bushek, 2012). The increased activity of H. nelsoni in the north 
probably represents the influence of climate change, with the parasite (and possibly its 
unidentified intermediate host) expanding its distribution northward and encoun-
tering relatively naive host populations. In the Mid-Atlantic, the parasite has been long 
established, providing the host more time to adapt to its presence (Ford and Bushek, 
2012).  
H. costale occurs from the Mid-Atlantic coast of the USA to the Atlantic Provinces of 
Canada (ICES, 2003) and reportedly has also been observed more frequently in nor- 
thern waters, but this could reflect increased surveillance more than differences in 
pathogen dynamics in those areas. There is no evidence that H. costale contributes more 
than occasionally to substantial oyster mortality in eastern North America. H. costale 
was observed in 2008 in C. gigas in British Columbia at 4-10% prevalence (ICES, 2009). 
The distribution of H. armoricanum includes the Netherlands and both Atlantic and 
Mediterranean coasts of France (Hine et al., 2007) as well as Spain (Azevedo et al., 1999), 
with a likely recent observation in Ireland (Lynch et al., 2013). H. edule occurs in north-
west Spain (Azevedo et al., 2003) and M. tapetis occurs in northwest Spain and Portugal 
(Vilela, 1951; Azevedo, 2001), but both of these pathogens were detected in in 2009 in 
Wales (ICES, 2010). An undescribed haplosporidian basal to the described genera was 
observed in 2002 in R. decussatus from Spain at high prevalence (to 71%) but without 
associated mortality (Novoa et al., 2004); this pathogen has not been reported since. 
7.4.3 Short Description of Clinical Signs 
Haplosporidiosis generally involves invasion of hemal spaces in host connective tis-
sues by uninucleate or plasmodial forms, followed by the production of masses of 
operculate spores in those tissues. One species of the derived haplosporidian genus 
Bonamia, B. perspora, presents a typical haplosporidiosis in its oyster host (Carnegie et 
al., 2006), but none of the other Bonamia species do. H. nelsoni, sporulating in host di-
gestive tubule epithelia, is a notable exception with regard to tissue tropism (Couch et 
al., 1966).  
7.4.4 Control/Preventative Measures 
No haplosporidiosis is listed as notifiable by either the World Organisation for Animal 
Health (OIE) or the EU (Directive 2006/88/EC). Infection with H. nelsoni is on the list of 
Federally Reportable Aquatic Animal Diseases – Molluscs for Canada. Limited un-
derstanding of the presumably indirect life cycles of these pathogens limits options for 
their control. Breeding for resistance to H. nelsoni in the eastern USA has been highly 
successful (Haskin and Ford, 1979; Ragone Calvo et al., 2003). 
7.4.5 Host Species 
H. nelsoni infects oysters C. virginica and C. gigas (Haskin et al. 1966; Burreson et al. 
2000). H. costale infects C. virginica (Wood and Andrews, 1962) and has been reported 
recently from C. gigas in British Columbia, Canada. H. armoricanum infects oyster O. 
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edulis (Van Banning, 1977). H. edule infects cockle C. edule (Azevedo et al., 2003). M. 
tapetis infects clam R. decussatus (Vilela, 1951). 
7.5 Perkinsosis 
7.5.1 Description of Agent 
Perkinsosis is caused by protozoan parasites in the genus Perkinsus, order Perkinsida 
(Levine, 1978). Infections by Perkinsus parasites have been noted in a number of marine 
molluscs, primarily of the classes Bivalvia and Gastropoda. Seven species are presently 
accepted, P. marinus, P. olseni, P. chesapeaki, P. mediterraneus, P. beihaiensis, P. honshuen-
sis, and P. qugwadi. Of these, P. marinus and P. olseni have been the most impactful on 
host populations and associated industries. Perkinsus parasites typically occur extrace-
llularly in host connective tissues, with both uninucleate trophozoites and multinu-
cleate schizonts observed, but P. marinus displays a distinct tropism for digestive epi-
thelia (Carnegie and Burreson, 2012), a habit that it may share with P. beihaiensis (Moss 
et al., 2008). P. qugwadi is unique in expressing zoospore forms within host tissues (Bla-
ckbourn et al., 1998).  
7.5.2 Geographical Distribution and Temporal Trends 
Of the two major Perkinsus pathogens, P. marinus occurs from the northeastern USA to 
Mexico in the western Atlantic Ocean and Gulf of Mexico, with colonization of the Pa-
cific coast of Mexico presumed to be a recent event (Caceres-Martinez et al., 2008). It 
was recently detected as well in Brazil (Da Silva et al., 2013). P. olseni was described 
from Australia (Lester and Davis, 1981) but occurs widely in Asia and southern Europe 
as well as in New Zealand (Dungan et al., 2007), and more recent work has found it in 
Uruguay and Brazil along the Atlantic coast of South America (Cremonte et al., 2005; 
Da Silva et al., 2014). Anthropogenic contributions to the distribution of P. olseni are not 
known.  
The recent observations of P. chesapeaki, described from the eastern USA, in Europe 
(Arzul et al., 2012; Carrasco et al., 2014) and Australia (Dang et al., 2015), and of P. 
beihaiensis, described from China (Moss et al., 2008), in Brazil (Sabry et al., 2009) and 
India (Sanil et al., 2012) are noteworthy. As for P. olseni, however, it is not clear to what 
extent these observations represent emergence of established pathogens in new loca-
tions; the discoveries may be a product of increased surveillance. P. qugwadi reemerged 
at one location in British Columbia, Canada, in 2011 after not having been observed 
anywhere since 1997 (Itoh et al., 2013). 
7.5.3 Short Description of Clinical Signs 
While very small (2-3 µm) P. marinus can be phagocytosed by host hemocytes and dis-
tributed generally through host hemal spaces, larger Perkinsus species are frequently 
observed as clusters or masses of parasite cells surrounded and sometimes encapsula-
ted by host hemocytes (Blackbourn et al., 1998; McLaughlin and Faisal, 1998; Burreson 
et al., 2005; Park et al., 2006). Infections reaching high intensities can be lethal, and in-
fection by P. marinus has caused mortality exceeding 70% (Burreson and Ragone Calvo, 
1996). Emaciation has long been considered a hallmark of perkinsosis caused by P. ma-
rinus and continues to be observed in association with heavy infections, although this 
clinical presentation can have numerous other causes (Carnegie and Burreson, 2012). 
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7.5.4 Control/Preventative Measures 
Both P. marinus and P. olseni are notifiable to the World Organisation for Animal Health 
(OIE). Infection with P. marinus is listed by the EU (Directive 2006/88/EC) and on the 
list of Federally Reportable Aquatic Animal Diseases – Molluscs for Canada. Infection 
with P. olseni is on the Canadian list and the US National List of Reportable Animal 
Diseases as well. As Perkinsus parasites are directly transmissible and easily spread 
with transfer of infected stocks, avoiding introduction to new areas with movement of 
infected shellfish is critical. In P. marinus-enzootic areas of the USA, control of P. ma-
rinus in aquaculture populations through selective breeding for disease-resistant oys-
ters has been successful (Ragone Calvo et al., 2003). 
7.5.5 Host Species 
P. marinus infects the eastern oyster C. virginica (Mackin et al., 1950) but also oysters C. 
corteziensis (Caceres-Martinez et al., 2008), S. palmula (Caceres-Martinez et al., 2012), and 
C. rhizophorae (Da Silva et al., 2013). P. olseni (= P. atlanticus) was described from the 
abalone H. ruber (Lester and Davis, 1981) but infects a wide range of bivalve and gas-
tropod species, notably including Manila clam R.  philippinarum in Asia (Choi and Park, 
1997) and Europe (Navas et al. 1992). P. chesapeaki (= P. andrewsi) infects clams Macoma 
balthica (Coss et al., 2001), Mya arenaria and Tagelus plebeius (Dungan et al., 2002), Cyrto-
pleura costata (Reece et al. 2008), and R. decussatus and R. philippinarum (Arzul et al., 
2012), cockle C. edule (Carrasco et al., 2014), and the ark Anadara trapezia (Dang et al., 
2015). P. beihaiensis infects oysters C. hongkongensis and C. ariakensis (Moss et al. 2008), 
C. rhizophorae (Sabry et al., 2009), and C. madrasensis (Sanil et al., 2012), and clam Ano-
malocardia brasiliana (Ferreira et al., 2015). P. mediterraneus infects oyster O. edulis (Casas 
et al., 2004) and ark Arca noae and scallop Chlamys varia (Ramilo et al., 2015). P. hons-
huensis infects the clam R. philippinarum (Dungan and Reece, 2006). P. qugwadi infects 
the scallop Patinopecten yessoensis (Blackbourn et al., 1998).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
New Trends in Important Diseases Affecting the Culture of Fish 
and Molluscs in the ICES Area 2002 – 2015 |  39 
 
 
Molluscan References 
Abollo, E., Ramilo, A., Casas, S.M., Comesana, P., Cao, A., Carballal, M.J. and Villalba A. 2008. 
First detection of the protozoan parasite Bonamia exitiosa (Haplosporidia) infecting flat oys-
ter Ostrea edulis grown in European waters. Aquaculture 274: 201–207. 
Arzul, I., Nicolas, J. L., Davison, A. J. , Renault, T. 2001. French scallops: a new host for ostreid 
herpesvirus 1. Virology 290: 342-349. 
Arzul, I., Chollet, B., Michel, J., Robert, M., Garcia, C., Joly, J.P., Francois, C. and Miossec, L. 2012. 
One Perkinsus species may hide another: characterization of Perkinsus species present in 
clam production areas of France. Parasitology 139: 1757−1771. 
Arzul, A., Chollet, B., Boyer, S., Bonnet, D., Gaillard, J., Baldi, Y., Robert, M., Joly, J.P., Garcia, C. 
and Bouchoucha, M. 2014. Contribution to the understanding of the cycle of the protozoan 
parasite Marteilia refringens. Parasitology 141: 227-240. 
Audemard, C., Barnaud, A., Collins, C.M., Le Roux, F., Sauriau, P.G., Coustau, C., Blachier, P. 
and Berthe, F.C.J., 2001. Claire ponds as an experimental model for Marteilia refringens lifecy-
cle studies: new perspectives. Journal of Experimental Marine Biology and Ecology 257: 87–108. 
Audemard, C., Le Roux, F., Barnaud, A., Collins, C., Sautour, B., Sauriau, P.G., De Montaudouin, 
X., Coustau, C., Combes, C. and Berthe, F. 2002. Needle in a haystack: involvement of the 
copepod Paracartia grani in the life-cycle of the oyster pathogen Marteilia refringens. Parasit-
ology 124: 315–323. 
Azevedo, C. 2001. Ultrastructural description of the spore maturation stages of the clam parasite 
Minchinia tapetis (Vilela, 1951) (Haplosporida: Haplosporidiidae). Systematic Parasitology 49: 
189–194. 
Azevedo, C., Conchas, R.F. and Montes, C. 2003. Description of Haplosporidium edule n. sp. (Phy-
lum Haplosporidia), a parasite of Cerastoderma edule (Mollusca, Bivalvia) with complex 
spore ornamentation. European Journal of Protistology 39: 161–167. 
Azevedo, C., Montes, J. and Corral, L. 1999. A revised description of Haplosporidium armoricanum, 
parasite of Ostrea edulis L. from Galicia, northwestern Spain, with special reference to the 
spore-wall filaments. Parasitology Research 85: 977–983. 
Azandégbé, A., Garnier, M., Andrieux-Loyer, F., Kérouel, R, Philippon, X., Nicolas, J. L. 2010. 
Occurrence and seasonality of Vibrio aestuarianus in sediment and Crassostrea gigas haemo-
lymph at two oyster farms in France. Diseases of Aquatic Organisms 91: 213-221.  
Balseiro, P., Aranguren, R., Gestal, C., Novoa, B. and Figueras, A. 2006. Candidatus Xenohaliotis 
californiensis and Haplosporidium montforti associated with mortalities of abalone Haliotis 
tuberculata cultured in Europe. Aquaculture 258: 63-72. 
Berthe, F.C.J., Le Roux, F., Adlard, R.D. and Figueras, A. 2004. Marteiliosis in molluscs: A review. 
Aquatic Living Resources 17: 433–448. 
Blackbourn, J., Bower, S.M. and Meyer, G.R. 1998. Perkinsus qugwadi sp. nov. (incertae sedis), a 
pathogenic protozoan parasite of Japanese scallops, Patinopecten yessoensis, culture in British 
Columbia, Canada. Canadian Journal of Zoology 76: 942-953. 
Bower, S. M., Goh, B. and Meyer, G. R. 2005. Epizootiology and detection of nocardiosis in oys-
ters. In P. Walker, R. Lester and M.G. Bondad-Reantaso (eds). Diseases in Asian Aquaculture 
V, pp 249-262. Fish Health Section, Asian Fisheries Society, Manila. 
Bower, S. M., Itoh, N., Choi, D.-L., Park, M.S. (2011): Synopsis of Infectious Diseases and Para-
sites of Commercially Exploited Shellfish: Marteilioides chungmuensis of Oysters. 
http://www.dfo-mpo.gc.ca/science/aah-saa/diseases-maladies/mcoy-eng.html. 
Burreson, E.M. and Ford, S.E. 2004. A review of recent information on the Haplosporidia, with 
special reference to Haplosporidium nelsoni (MSX disease). Aquatic Living Resources 17: 499–
517. 
40  | ICES Cooperative Research Report 337 
 
 
Burreson, E.M. and Ragone Calvo, L.M. 1996. Epizootiology of Perkinsus marinus disease of oys-
ters in Chesapeake Bay, with emphasis on data since 1985. Journal of Shellfish Research 15: 17–
34. 
Burreson, E.M. and Reece, K.S. 2006. Spore ornamentation of Haplosporidium nelsoni and Haplo-
sporidium costale (Haplosporidia), and incongruence of molecular phylogeny and spore or-
namentation in the Haplosporidia. Journal of Parasitology 92: 1295-1301. 
Burreson, E.M., Dungan, C.F. and Reece, K.S. 2005. Molecular, morphological, and experimental 
evidence support the synonymy of Perkinsus chesapeaki and Perkinsus andrewsi. Journal of Eu-
karyotic Microbiology 52: 258-270. 
Burreson, E.M., Stokes, N.A. and Friedman, C.S. 2000. Increased virulence in an introduced path-
ogen: Haplosporidium nelsoni (MSX) in the eastern oyster Crassostrea virginica. Journal of 
Aquatic Animal Health 12: 1–8. 
Cáceres-Martínez, J., Vásquez-Yeomans, R., Padilla-Lardizábal, G. and del Río Portilla, M.A. 
2008. Perkinsus marinus in pleasure oyster Crassostrea corteziensis from Nayarit, Pacific coast 
of México. Journal of Invertebrate Pathology 99: 66-73. 
Cáceres-Martínez, J., García Ortega, M., Vásquez-Yeomans, R., Pineda García, T.J., Stokes, N.A. 
and Carnegie, R.B. 2012. Natural and cultured populations of the mangrove oyster Saccostrea 
palmula from Sinaloa, Mexico, infected by Perkinsus marinus. Journal of Invertebrate Pathology 
110: 321-325. 
Carella, F., Carrasco, N., Andree, K. B., Lacuesta, B., Furones, D., and De Vico, G. 2013. Nocardi-
osis in Mediterranean bivalves: first detection of Nocardia crassostreae in a new host Mytilus 
galloprovincialis and in Ostrea edulis from the Gulf of Naples (Italy).  Journal of Invertebrate 
Pathology 114: 324-328. 
Carnegie, R.B. and Burreson, E.M. 2011. Declining impact of an introduced pathogen: Haplospor-
idium nelsoni in the oyster Crassostrea virginica in Chesapeake Bay. Marine Ecology Progress 
Series 432: 1-15. 
Carnegie, R.B. and Burreson, E.M. 2012. Perkinsus marinus and Haplosporidium nelsoni. Pages 92-
108 in: Fish Parasites: Pathobiology and Protection (P.T.K. Woo and K. Buchmann, eds.). CABI 
Publishing, Oxfordshire, UK. 
Carnegie, R.B., Hill, K.M., Stokes, N.A. and Burreson, E.M. 2014. The haplosporidian Bonamia 
exitiosa is present in Australia, but the identity of the parasite described as Bonamia roughleyi 
is uncertain. Journal of Invertebrate Pathology 115: 33-40. 
Carnegie, R.B., B.J. Barber, S.C. Culloty, A.J. Figueras, and D.L. Distel. 2000.  Development of a 
PCR assay for detection of the oyster pathogen Bonamia ostreae (Pichot et al. 1980), and sup-
port for its inclusion in the Haplosporidia.  Diseases of Aquatic Organisms 42: 199-206. 
Carnegie, R.B., Burreson, E.M., Hine, P.M., Stokes, N.A., Audemard, C., Bishop, M.J. and Peter-
son, C.H., 2006. Bonamia perspora n. sp. (Haplosporidia), a parasite of the oyster Ostreola 
equestris, is the first Bonamia species known to produce spores. Journal of Eukaryotic Microbi-
ology 53: 232–245. 
Carrasco, N., López-Flores, I., Alcaraz, M., Furones, M.D., Berthe, F. and Arzul, I., 2007. Dynam-
ics of the parasite Marteilia refringens (Paramyxea) in Mytilus galloprovincialis and zooplank-
ton populations in Alfacs Bay (Catalonia, Spain). Parasitology 134: 1541–1550. 
Carrasco, N., Rojas, M., Aceituno, P., Andree, K.B., Lacuesta, B. and Furones, M.D. 2014. 
Perkinsus chesapeaki observed in a new host, the European common edible cockle Cerasto-
derma edule, in the Spanish Mediterranean coast. Journal of Invertebrate Pathology 117: 56−60. 
Carrasco, N., Roque, A., Andree, K.B., Rodgers, C., Lacuesta, B. and Furones, M.D. 2011. A Mar-
teilia parasite and digestive epithelial virosis observed during a common edible cockle Ce-
rastoderma edule mortality event in the Spanish Mediterranean coast. Aquaculture 321: 197–
202. 
New Trends in Important Diseases Affecting the Culture of Fish 
and Molluscs in the ICES Area 2002 – 2015 |  41 
 
 
Carrasco, N., Hine, P.M., Durfort, M., Andree, K.B., Malchus, N., Lacuesta, B., González, M., 
Roque, A., Rodgers, C. and Furones, M.D. 2013. Marteilia cochillia sp. nov., a new Marteilia 
species affecting the edible cockle Cerastoderma edule in European Waters. Aquaculture 412-
413: 223−230. 
Casas, S.M., Grau, A., Reece, K.S., Apakupakul, K., Azevedo, C. and Villalba, A. 2004. Perkinsus 
mediterraneus n. sp., a protistan parasite of the European flat oyster Ostrea edulis from the 
Balearic Islands, Mediterranean Sea. Diseases of Aquatic Organisms 58: 231-244. 
Cavalier-Smith, T. and Chao E.E.-Y. 2003. Phylogeny of Choanozoa, Apusozoa, and other proto-
zoa and early eukaryote megaevolution. Journal of Molecular Evolution 56: 540-563. 
Choi, K.S. and Park, K.I. 1997. Report on the occurrence of Perkinsus sp. in the Manila clams, 
Ruditapes philippinarum in Korea. Journal of the Korean Aquaculture Society 10: 227−237. 
Clegg, T.A., Morrissey, T., Geoghegan, F., Martin, S.W., Lyons, K., Ashe, S. and More, S.J. 2014. 
Risk factors associated with increased mortality of farmed Pacific oysters in Ireland during 
2011. Preventive Veterinary Medicine 113: 257-267. 
Comps, M., Park, M.S. and Desportes, I. 1986. Ultrastructural study of Marteilioides chungmuensis 
gen. nov., sp. nov., a parasite of the ovocytes of the oyster Crassostrea gigas Th. Protistologica 
22: 279–285. 
Comps M., Pichot, Y. and Papagianni, P. 1982. Recherche sur Marteilia maurini n. sp. parasite de 
la moule Mytilus galloprovincialis Lmk. Rev. Trav. Inst. Pêches Marit. 45: 211–214. 
Comps, M., Tigé, G., and Grizel, H. 1980. Etude ultrastructurale d’un protiste parasite de l’huître 
Ostrea edulis L. LCR Academy of Science Paris, Série D 290, 383–385. 
Conchas, R.F., Santamarina, J., Lama, A., Longa, M.A., and Montes, J. 2003. Evolution of 
bonamiosis in Galicia (NW Spain). Bulletin of the European Association of Fish Pathologists 23, 
265–272. 
Corbeil, S., Arzul, I., Robert, M., Berthe, F.C.J., Besnard-Cochennec, N. and Crane, M.S.J. 2006. 
Molecular characterization of an Australian isolate of Bonamia exitiosa. Diseases of Aquatic 
Organisms 71 : 81-85. 
Coss, C.A., Robledo, J.A.F., Ruiz, G.M. and Vasta, G.R. 2001. Description of Perkinsus andrewsi n. 
sp. isolated from the Baltic clam (Macoma balthica) by characterization of the ribosomal RNA 
locus, and development of a species-specific PCR-based diagnostic assay. Journal of Eukary-
otic Microbiology 48: 52-61. 
Couch, J.A., Farley, C.A and Rosenfield, A. 1966. Sporulation of Minchinia nelsoni (Haplosporida, 
Haplosporidiidae) in Crassostrea virginica (Gmelin). Science 153: 1529-1531. 
Cremonte, F., Balseiro, P. and Figueras, A. 2005 Occurrence of Perkinsus olseni (Protozoa: 
Apicomplexa) and other parasites in the venerid commercial clam Pitar rostrata from Uru-
guay, southwestern Atlantic coast. Diseases of Aquatic Organisms 64: 85−90. 
Cranfield, H.J., Dunn, A., Doonan, I.J. and Michael, K.P. 2005. Bonamia exitiosa epizootic in Ostrea 
chilensis from Foveaux Strait, southern New Zealand between 1986 and 1992. ICES Journal 
of Marine Science 62 : 3–13. 
Culloty, S.C. and Mulcahy, M.F. 1996. Season-, age-, and sex-related variation in the prevalence 
of bonamiosis in flat oysters (Ostrea edulis L.) on the south coast of Ireland. Aquaculture 144, 
53–63. 
Dang, C., Dungan, C.F., Scott, G.P. and Reece, K.S. 2015. Perkinsus sp. infections and in vitro iso-
lates from Anadara trapezia (mud arks) of Queensland, Australia. Diseases of Aquatic Organ-
isms 113: 51-58.  
da Silva, P.M., Scardua, M.P., Vianna, R.T., Mendonça, R.C., Vieira, C.B., Dungan, C.F., Scott, 
G.P., and Reece, K.S. 2014. Two Perkinsus spp. infect Crassostrea gasar oysters from cultured 
and wild populations of the Rio São Francisco estuary, Sergipe, northeastern Brazil. Journal 
of Invertebrate Pathology 119: 62−71. 
42  | ICES Cooperative Research Report 337 
 
 
da Silva, P.M., Vianna, R.T., Guertler, C., Ferreira, L.P., Santana, L.N., Fernandez-Boo, S., Ramilo, 
A., Cao, A. and Villalba, A. 2013. First report of the protozoan parasite Perkinsus marinus in 
South America, infecting mangrove oysters Crassostrea rhizophorae from the Paraiba River 
(NE, Brazil). Journal of Invertebrate Pathology 113: 96-103. 
Davison, A.J., Trus, B.L., Cheng, N., Steven, A.C., Watson, M.S., Cunningham, C., Le Deuff, R.M. 
and Renault, T. 2005. A novel class of herpesvirus with bivalve hosts. Journal of General 
Virology 86: 41–53. 
Dinamani, P., Hine, P.M. and Jones, J.B. 1987. Occurrence and characteristics of the haemocyte 
parasite Bonamia sp. in the New Zealand dredge oyster Tiostrea lutaria. Diseases of Aquatic 
Organisms 3: 37–44. 
Dundon, W. G., Arzul, I., Omnes, E., Robert, M., Magnabosco, C., Zambon, M., Gennari, L., 
Toffan, A., Terregino, C., Capua, I., and Arcangeli, G. 2011. Detection of Type 1 Ostreid 
Herpes variant (OsHV-1 µvar) with no associated mortality in French-origin Pacific cupped 
oyster Crassostrea gigas farmed in Italy. Aquaculture 314: 49-52. 
Dungan, C.F. and K.S. Reece. 2006. In vitro propagation of two Perkinsus spp. parasites from 
Japanese Manila clams Venerupis philippinarum, and description of Perkinsus honshuensis n. 
sp. Journal of Eukaryotic Microbiology 53: 316-326. 
Dungan, C.F., Hamilton, R.M., Hudson, K.L., McCollough, C.B. and Reece, K.S. 2002 Two epizo-
otic diseases in Chesapeake Bay commercial clams, Mya arenaria and Tagelus plebeius. Dis-
eases of Aquatic Organisms 50: 67−78. 
Dungan, C.F., Reece, K.S., Moss, J.A., Hamilton, R.M. and Diggles, B.K. 2007. Perkinsus olseni in 
vitro isolates from the New Zealand clam Austrovenus stutchburyi. Journal of Eukaryotic Mi-
crobiology 54: 263−270. 
EFSA. 2010. Scientific Opinion of the Panel on Animal Health and Welfare on a request from the 
European Commission on the increased mortality events in Pacific oysters Crassostrea gigas. 
EFSA Journal 8:1894-1853. 
Elgharsalli, R., Aloui-Bejaoui, N., Salah, H., Chollet, B., Joly, J.-P., Robert, M., Couraleau, Y. and 
Arzul, I. 2013. Characterization of the protozoan parasite Marteilia refringens infecting the 
dwarf oyster Ostrea stentina in Tunisia. Journal of Invertebrate Pathology 112: 175-183. 
Engelsma, MY, Roozenburg, I. and Joly, J.P. 2008. First isolation of Nocardia crassostreae from 
Pacific oyster Crassostrea gigas in Europe. Diseases of Aquatic Organisms 80:229-234. 
Engelsma, M.Y., Kerkhoff, S., Roozenburg, I., Haenen, O.L.M., Van Gool, A., Istermans, W., 
Wijnhoven, S., and Hummel, H. 2010. Epidemiology of Bonamia ostreae infecting European 
flat oyster Ostrea edulis from Lake Grevelingen, The Netherlands. Marine Ecology Progress 
Series 409, 131–142. 
Feist, S.W., Hine, M.P., Bateman, K.S., Steinford, G.D. and Longshaw, M., 2009. Paramarteilia can-
ceri sp. n. (Cercozoa) in the European edible crab (Cancer pagurus) with a proposal for the 
revision of the order paramyxida Chatton, 1911. Folia Parasitologica 56: 73–85. 
Ferreira, L.P., Sabry, R.C., da Silva, P.M., Gesteira, T.C.V., Romao, L.D., Paz, M.P., Feijó, R.G., 
Neto, M.P.D. and Maggioni, R. 2015. First report of Perkinsus beihaiensis in wild clams Anom-
alocardia brasiliana (Bivalvia: Veneridae) in Brazil. Experimental Parasitology 150: 67-70. 
Figueras, A.J. and Montes, J. 1988. Aber disease of edible oysters caused by Marteilia refringens. 
American Fisheries Society Special Publication 18: 38-46. 
Ford, S.E. 1996. Range extension by the oyster parasite Perkinsus marinus into the northeastern 
United States: response to climate change? Journal of Shellfish Research 15: 45–56. 
Ford, S.E. and Bushek, D. 2012. Development of resistance to an introduced marine pathogen by 
a native host. Journal of Marine Research 70: 205-223. 
New Trends in Important Diseases Affecting the Culture of Fish 
and Molluscs in the ICES Area 2002 – 2015 |  43 
 
 
Friedman, C.S. and Finley C.A. 2003. Evidence for an anthropogenic introduction of “Candidatus 
Xenohaliotis californiensis”, the etiological agent of withering syndrome, into northern Cal-
ifornia abazlone population via conservation efforts. Canadian Journal of Fisheries and Aquatic 
Sciences 60: 1424-1431. 
Friedman, C.S., Beattie, J. H., Elston, R.A. and Hedrick, R.P. 1991. Investigation of the relation-
ship between the presence of a Gram-positive bacterial infection and summer mortality of 
the Pacific oyster, Crassostrea gigas Thunberg. Aquaculture 94: 1. 
Friedman, C.S., Beaman, B. L., Chun, J., Goodfellow, M., Gee, A.and Hedrick, R.P. 1998. Nocardia 
crassostreae sp. nov., the causal agent of nocardiosis in Pacific oysters. International Journal of 
Systematic Bacteriology 48 Pt 1: 237-46. 
Friedman, C.S., Andree, K.B., Beauchamps, K.A., Moore, J.D., Robbins, T.T., Shields, J.D., and 
Hedrick, R.P. 2000. “Candidatus Xenohaliotis californiensis” a newly described pathogen of 
abalone, Haliotis spp., along the west coast of North America. International Journal of System-
atic Evolution and Microbiology 50: 847-855. 
Garcia, C., Thébault, A., Dégremont, L., Arzul, I., Miossec, L., Robert, M., Chollet, B., François, 
C., Joly, J.-P., Ferrand, S., Kerdudou, N. and Renault, T. 2011. OsHV-1 detection and rela-
tionship with C. gigas spat mortality in France between 1998 and 2006. Veterinary Research 
42 : 73–84. 
Gardner, G.R., Harshbarger, J.C., Lake, J., Sawyer, T.K., Price, K.L., Stephenson, M.D., Haaker, 
P.L., Togstad, H.A. 1995. Association of prokaryotes with symptomatic appearance of with-
ering syndrome in black abalone Haliotis cracherodii. Journal of Invertebrate Pathology 66: 111-
120. 
Garnier, M., Y. Labreuche, C. Garcia, M. Robert and J.L. Nicolas. 2007. Evidence for the Involve-
ment of Pathogenic Bacteria in Summer Mortalities of the Pacific Oyster Crassostrea gigas. 
Microbial Ecology 53: 187-196. 
Garnier, M., Y. Labreuche, and Nicolas, J. L. 2008 Molecular and phenotypic characterization of 
Vibrio aestuarianus subsp. francensis subsp. nov., a pathogen of the oyster Crassostrea gigas. 
Systematic and Applied Microbiology 31: 358-365. 
Gay, M., Renault, T., Pons, A.M. and Le Roux, F. 2004. Two Vibrio splendidus related strains col-
laborate to kill Crassostrea gigas: taxonomy and host alterations. Diseases of Aquatic Organisms 
62: 65-74. 
Gay, M., Lancelot, G., Chollet, B., Renault, T., Cochennec, C., Berthe, F.J., Lambert, C., Choquet, 
G., Paillard, C., Gouy, M., Le Roux, F. and Goulletquer, P. 2003. Characterisation of Vibrio 
isolated from Pacific oysters spat suffering from Summer Mortality outbreaks. Journal of 
Shellfish Research 22: 331.  
Gomez-Gil, B., Soto-Rodriguez, S., Garcia-Gasca, A., Roque, A., Vazquez-Juarez, R., Thompson, 
F.L. and Swings, J., 2004. Molecular identification of Vibrio harveyi-related isolates associated 
with diseased aquatic organisms. Microbiology 150: 1769-1777. 
Grizel H. 1985. Etudes des récentesépizooties de l’huître plate Ostrea edulis L. et de leur impact 
sur l’ostréiculture bretonne. Thèse de doctorat, Université des Sciences etTechniques de 
Languedoc, Montpellier, France. 
Grizel, H., Comps, M., Bonami, J.R., Cousserans, F., Duthoit, J.L. and Pennec, M. 1974. Epizooty 
of the common oyster Ostrea edulis. Part 1. Study of the agent of digestive gland disease in 
Ostrea edulis (Linne). Sciences Peche 1–30. 
Handlinger, J., Carson, J., Donachie, L., Gabor, L. and Taylor, D. 2005. Bacterial Infection in Tas-
manian Farmed Abalone: Causes, Pathology,  Farm  Factors and Control Options. Diseases 
in  Asian Aquaculture. P. Walker, R. Lester and M.G.  Bondad-Reantaso (Eds). Fish Health 
Section. 
44  | ICES Cooperative Research Report 337 
 
 
Haskin, H.H. and Ford, S.E. 1979. Development of resistance to Minchinia nelsoni (MSX) mortality 
in laboratory-reared and native oyster stocks in Delaware Bay. Marine Fisheries Review 41: 
54–63. 
Haskin, H.H., Stauber, L.A. and Mackin, J.A. 1966 Minchinia nelsoni n. sp. (Haplosporida, Hap-
losporidiidae): causative agent of the Delaware Bay oyster epizootic. Science 153: 1414–1416. 
Herrbach, B. 1971. Sur une affection parasitaire de la glande digestive de l’huitre plate, Ostrea 
edulis Linne. Revue des Travaux de l’Institut des Peches Maritimes. 35: 79-87. 
Hill, K.M., Carnegie, R.B., Aloui-Bejaoui, N., El Gharsalli, R., White, D., Stokes, N.A. and Burre-
son, E.M. 2010. Observation of a Bonamia sp. infecting the oyster Ostrea stentina in Tunisia, 
and a consideration of its phylogenetic affinities. Journal of Invertebrate Pathology 103: 179-
185. 
Hill, K.M., Stokes, N.A., Webb, S.C., Hine, P.M., Kroeck, M.A., Moore, J.D., Morley, M.S., Reece, 
K.S., Burreson, E.M. and Carnegie, R.B. 2014. Phylogenetics of Bonamia parasites based on 
small subunit and internal transcribed spacer region ribosomal DNA sequence data. Diseases 
of Aquatic Organisms 110: 33-54. 
Hine, P.M. 1991. The annual pattern of infection by Bonamia sp. in New Zealand flat oysters, 
Tiostrea chilensis. Aquaculture 93: 241–251. 
Hine, P. M. 1996. The ecology of Bonamia and decline of bivalve molluscs. New Zealand Journal of 
Ecology 20: 109–116. 
Hine, P.M. and Jones, J.B. 1994. Bonamia and other aquatic parasites of importance to New Zea-
land. New Zealand Journal of Zoology 21: 49–56. 
Hine, P.M. and Wesney, B. 1994. The functional cytology of Bonamia sp. (Haplosporidia) infecting 
oysters Tiostrea chilensis: an ultracytochemical study. Diseases of Aquatic Organisms 20: 207-
217. 
Hine, P.M., Diggles, B.K., Parsons, M.J.D., Pringle, A. And Bull, B. 2002. The effects of stressors 
on the dynamics of Bonamia exitiosus Hine, Cochennec-Laureau & Berthe, infections in flat 
oysters Ostrea chilensis (Philippi). Journal of Fish Diseases 25: 545-554. 
Hine, P.M., Engelsma, M.Y. and Wakefield, S.J. 2007. Ultrastructure of sporulation in Haplospor-
idium armoricanum. Diseases of Aquatic Organisms 77: 225–233. 
Huchette, S.M.H. and Clavier, J. 2004. Status of the ormer (Haliotis tuberculata L.) industry in 
Europe. Journal of Shellfish Research 23: 951-955. 
ICES. 2003. Report of the Working Group on Pathology and Diseases of Marine Organisms 
(WGPDMO), 11-15 March 2003, Aberdeen, United Kingdom. ICES CM 2003/F:03. 101 pp. 
ICES. 2008. Report of the Working Group on Pathology and Diseases of Marine Organisms 
(WGPDMO), 4-8 March 2008, Galway, Ireland. ICES CM 2008/MCC:01. 128 pp. 
ICES. 2009. Report of the Working Group on Pathology and Diseases of Marine Organisms 
(WGPDMO), 24-28 February 2009, Riga, Latvia. ICES CM 2009/MCC:01. 119 pp. 
ICES. 2010. Report of the Working Group on Pathology and Diseases of Marine Organisms 
(WGPDMO), 23-27 February 2010, Uppsala, Sweden. ICES CM 2010/SSGHIE:02. 66 pp. 
ICES. 2011. Report of the Working Group on Pathology and Diseases of Marine Organisms 
(WGPDMO), 1-5 March 2015, Aberdeen, United Kingdom. ICES CM 2015/SSGHIE:04. 58 
pp. 
ICES. 2012. Report of the Working Group on Pathology and Diseases of  Marine Organisms 
(WGPDMO), 31 January - 4 February 2012, Lisbon, Portugal. ICES CM 2012/SSGHIE:03. 74 
pp. 
ICES. 2015. Report of the Working Group on Pathology and Diseases of Marine Organisms 
(WGPDMO), 24-28 February 2015, Helsinki, Finland. ICES CM 2015/SSGEPI:01. 124 pp. 
New Trends in Important Diseases Affecting the Culture of Fish 
and Molluscs in the ICES Area 2002 – 2015 |  45 
 
 
Itoh, N., Oda, T., Ogawa, K. and Wakabayashi, H. 2002. Identification and development of a 
paramyxean ovarian parasite in the Pacific oyster Crassostrea gigas (Thunberg). Fish Pathol-
ogy 37: 23–28. 
Itoh, N., Meyer, G.R., Tabata, A., Lowe, G., Abbott, C.L. and Johnson, S.C. 2013. Rediscovery of 
the Yesso scallop pathogen Perkinsus qugwadi in Canada, and development of PCR tests. 
Diseases of Aquatic Organisms 104: 83-91. 
Jenkins, C., Hick, P., Gabor, M., Spiers, Z., Fell, S. A., Gu, X., Read, A., Go, J., Dove, M., O'Connor, 
W., Kirkland, P. D. and Francesn J. 2013. Identification and characterisation of an ostreid 
herpesvirus-1 microvariant (OsHV-1 µ-var) in Crassostrea gigas (Pacific oysters) in Australia. 
Diseases of Aquatic Organisms 105: 109-126. 
Labreuche Y, Le Roux F, Henry J, Zatylny C, Huvet A, Lambert C, Soudant P, Mazel D, Nicolas 
JL. 2010. Vibrio aestuarianus zinc metalloprotease causes lethality in the Pacific oyster 
Crassostrea gigas and impairs the host cellular immune defenses. Fish & Shellfish Immunology 
29: 753-8. 
Lacoste, A., Jalabert, F., Malham, S., Cueff, A., Gélébart, F;, Cordevant, C., Lange, C. and Poulet, 
S. 2001. A Vibrio splendidus strain associated with Summer Mortality of juvenile oysters 
Crassostrea gigas in the bay of Morlaix (North Brittany, France). Diseases of Aquatic Organisms 
46: 139-145. 
Lane, H.S., Webb, S.C. and Duncan, J. 2016. Bonamia ostreae in the New Zealand oyster Ostrea 
chilensis: a new host and geographic record for this haplosporidian parasite. Diseases of 
Aquatic Organisms 118: 55–63. 
Le Deuff, R.-M. and Renault, T. 1999. Purification and partial genome characterization of a her-
pes-like virus infecting the Japanese oyster, Crassostrea gigas. Journal of General Virology 80: 
1317–1322. 
Le Roux, F., Gay, M., Lambert, C., Waechter, M., Poubalanne, S., Chollet, B., Nicolas, J.L. and 
Berthe, F. 2002. Comparative analysis of Vibrio splendidus-related strains isolated during 
Crassostrea gigas mortality events. Aquatic Living Resources 15: 251-258. 
Le Roux, F., Lorenzo, G., Peyret, P., Audemard, C., Figueras, A., Vivares, C., Gouy, M. and 
Berthe, F. 2001. Molecular evidence for the existence of two species of Marteilia in Europe. 
Journal of Eukaryotic Microbiology 48: 449–454. 
Lester, R.J.G. and Davis, G.H.G. 1981. A new Perkinsus species (Apicomplexa, Perkinsea) from 
the abalone Haliotis ruber. Journal of Invertebrate Pathology 37: 181−187. 
Levine, N.D. 1978. Perkinsus gen. n. and other new taxa in the protozoan phylum Apicomplexa. 
Journal of Parasitology 64: 549. 
López-Flores, I., de la Herran, R., Garrido-Ramos, M., Navas, J., Ruiz-Rejon, C. and Ruiz-Rejon, 
M. 2004. The molecular diagnosis of Marteilia refringens and differentiation between Marteilia 
strains infecting oysters and mussels based on the rDNA IGS sequence. Parasitology 129: 
411–419. 
Lynch, S.A., Armitage, D.V., Wylde, S., Mulcahy, M.F., and Culloty, S.C. 2005. The susceptibility 
of young prespawning oysters, Ostrea  edulis, to Bonamia ostreae. Journal of Shellfish Research 
24, 1019–1025. 
Lynch, S.A., Abollo, E., Ramilo, A., Culloty, S.C. and Villalba, A. 2010. Observations raise the 
question if the Pacific oyster, Crassotrea gigas, can act as either a carrier or a reservoir for 
Bonamia ostreae or Bonamia exitiosa. Parasitology 137, 1515-1526. 
Lynch, S.A., Villalba, A., Abollo, E., Engelsma, M., Stokes, N.A. and Culloty, S.C. 2013. The oc-
currence of haplosporidian parasites, Haplosporidium nelsoni and Haplosporidium sp., in oys-
ters in Ireland. Journal of Invertebrate Pathology 112: 208-212. 
Macián, M.C., Garay, E.., Gonzalez-Candelas, F., Pujalte, M.J. and Aznar, R. 2000. Ribotyping of 
vibrio populations associated with cultured oysters (Ostrea edulis). Systematic Applied Micro-
biology 23: 409–417. 
46  | ICES Cooperative Research Report 337 
 
 
Martenot, C., Oden, E., Travaillé, E., Malas, J.P. and Houssin, M. 2011. Detection of different 
variants of Ostreid Herpesvirus 1 in the Pacific oyster Crassostrea gigas. Virus Research 160: 
25-31. 
McLaughlin, S.M. and M. Faisal. 1998. Histopathological alterations associated with Perkinsus 
spp. infection in the softshell clam Mya arenaria. Parasite – Journal de la Societe Francaise de 
Parasitologie 5: 263-271. 
Montes, J., Anadron, R., and Azevedo, C. 1994. A possible life cycle for Bonamia ostreae on the 
basis of electron microscopy studies. Journal of Invertebrate Pathology 63, 1–6. 
Moss, J.A., Xiao, J., Dungan, C.F. and Reece, K.S. 2008. Description of Perkinsus beihaiensis n. sp., 
a new Perkinsus sp. parasite in oysters of southern China. Journal of Eukaryotic Microbiology 
55: 117−130. 
Moss, J.A., Burreson, E.M., Cordes, J.F., Dungan, C.F., Brown, G.D., Wang, A., Wu, X. and Reece, 
K.S. 2007. Pathogens in Crassostrea ariakensis and other Asian oyster species: implications for 
non-native oyster introduction to Chesapeake Bay. Diseases of Aquatic Organisms 77: 207–
223. 
Naciri-Graven, Y., Martin, A.G., Baud, J.P., Renault, T., and Gérard, A. 1998. Selecting the flat 
oyster Ostrea edulis (L.) for survival when infected with the parasite Bonamia ostreae. Journal 
of Experimental Marine Biology and Ecology 224, 91–107. 
Narcisi, V., Arzul, I., Cargini, D., Mosca, F., Calzetta, A., Traversa, D., Robert, M., Joly, J.P., 
Chollet, B., Renault, T. and Tiscar, P.G. 2010. Detection of Bonamia ostreae and Bonamia exi-
tiosa (Haplosporidia) in Ostrea edulis from the Adriatic Sea (Italy). Diseases of Aquatic Organisms 
89: 79–85. 
Navas, J.I., Castillo, M.C., Vera, P. and Ruizrico, M. 1992. Principal parasites observed in clams, 
Ruditapes decussatus (L), Ruditapes philippinarum (Adams et Reeve), Venerupis pullastra (Mon-
tagu) and Venerupis aureus (Gmelin), from the Huelva Coast (SW Spain). Aquaculture 107: 
193-199. 
Nicolas, J.L., Basuyaux, O., Mazurie, J. and Thebault, A. 2002. Vibrio carchariae, a pathogen of the 
abalone Haliotis tuberculata. Diseases of Aquatic Organisms 50: 35-43. 
Nishimori, E., Hasegawa, O., Numata, T. andbayashi, T. 1998. Vibrio carchariae causes mass mor-
talities in Japanese abalone, Sulculus diversicolor supratexta. Fish Pathology 33: 495-502. 
Novoa, B., Balseiro, P. and Figueras, A. 2004. Molecular detection of a haplosporidian parasite 
in carpet shell clam Ruditapes decussatus from Spain. Diseases of Aquatic Organisms 61: 89-93. 
Novoa, B., Posada, D. and Figueras, A. 2005. Polymorphisms in the sequences of Marteilia inter-
nal transcribed spacer region of the ribosomal RNA genes (ITS-1) in Spain: genetic types are 
not related with bivalve hosts. Journal of Fish Diseases 2: 331–338. 
Park, K.I., Ngo, T.T.T., Choi, S.D., Cho, M. and Choi, K.S. 2006. Occurrence of Perkinsus olseni in 
the Venus clam Protothaca jedoensis in Korean waters. Journal of Invertebrate Pathology 93: 81-
87. 
Peeler, J. E., Reese, R. A., Cheslett, D. L., Geoghegan, F., Power, A. and Trush, M. A. 2012. Inves-
tigation of mortality in Pacific oysters associated with Ostreid herpesvirus-1 µVar in the 
Republic od Ireland in 2009. Preventive Veterinary Medicine 105: 136-143. 
Perkins, F.O. and Wolf, P.H. 1976. Fine structure of Marteilia sydneyi sp. n. - Haplosporidian path-
ogen of Australian oysters. Journal of Parasitology 62: 528–538. 
Pichot, Y., Comps, M., Tige, G., Grizel, H., and Rabouin, M.A. 1979. Recherches sur Bonamia 
ostreae gen. n., sp. n., parasite nouveau de l’huitre plate Ostrea edulis L. Revue des Travaux de 
l’Institut des Peches Maritimes 43: 131-140. 
Ragone Calvo, L.M., Calvo, G.W. and Burreson, E.M. 2003. Dual disease resistance in a selec-
tively bred eastern oyster, Crassostrea virginica, strain tested in Chesapeake Bay. Aquaculture 
220: 69–87. 
New Trends in Important Diseases Affecting the Culture of Fish 
and Molluscs in the ICES Area 2002 – 2015 |  47 
 
 
Ramilo, A., Carrasco, N., Reece, K.S., Valencia, J.M., Grau, A., Aceituno, P., Rojas, M., Gairin, I., 
Furones, M.D., Abollo, E. and Villalba, A. 2015. Update of information on perkinsosis in NW 
Mediterranean coast: identification of Perkinsus spp. (Protista) in new locations and hosts. 
Journal of Invertebrate Pathology 125: 37-41. 
Reece, K.S., Dungan, C.F. and Burreson, E.M. 2008. Molecular epizootiology of Perkinsus marinus 
and P. chesapeaki infections among wild oysters and clams in Chesapeake Bay, USA. Diseases 
of Aquatic Organisms 82: 237−248. 
Renault, T., Le Deuff, R.-M., Cochennec, N. and Maffart, P. 1994. Herpesviruses associated with 
mortalities among Pacific oyster, Crassostrea gigas, in France – comparative study. Revue de 
Médecine Vétérinaire 145: 735–742. 
Renault, T., Moreau, P., Faury, N. Pepin, J.-F., Segarra, A. and Webb, S. 2012. Analysis of clinical 
Ostreid Herpesvirus 1 (Malacoherpesviridae) specimens by sequencing amplified fragments 
from three virus genome areas. Journal of Virology 86: 5942-5947. 
Renault, T., Stokes, N.A., Chollet, B., Cochennec, N., Berthe, F., Gérard, A. and Burreson, E.M. 
2000. Haplosporidiosis in the Pacific oyster Crassostrea gigas from the French Atlantic coast. 
Diseases of Aquatic Organisms 42: 207–214. 
Roque, A., Carrasco, N., Andree, K. B. Lacuesta, B., Elandaloussi, L. Gairin, I., Rodgers, C. J. and 
Furones, M. D. 2012. First report of OsHV-1 microvar in Pacific oyster (Crassostrea gigas) 
cultured in Spain. Aquaculture 324-325, 303-306. 
Sabry, R.C., Rosa, R.D., Magalhaes, A.R.M., Barracco, M.A., Gesteira, T.C.V. and da Silva, P.M. 
2009. First report of Perkinsus sp. infecting mangrove oysters Crassostrea rhizophorae from the 
Brazilian coast. Diseases of Aquatic Organisms 88: 14-23. 
Samain, J.F., Boudry, P., Degremont, L., Soletchnik, P., Ropert, M., Nicolas, J.L., Le Roux, L. Re-
nault, T., Burgeot, T. and Bacher C. 2004. Summer mortality in the Pacific Oyster Crassostrea 
gigas, overview of 3-year results of the cooperative “MOREST” Project. Journal of Sellfish Re-
search 23: 309-310. 
Sanil, N.K., Suja, G., Lijo, J. and Vijayan, K.K. 2012. First report of Perkinsus beihaiensis in 
Crassostrea madrasensis from the Indian subcontinent. Diseases of Aquatic Organisms 98: 209-
220. 
Saulnier, D., De Decker, S;, Haffner, P., Cobret, L., Robert, M. and Garcia, C. 2010. A large-scale 
epidemiologicval study to identify bacteria pathogenic to Pacific oyster Crassostrea gigas and 
correlation between virulence and metalloprotease-like activity. Microbial Ecology 59: 787-
798. 
Sauvage, C., Pépin, J.F., Lapègue, S., Boudry, P. and Renault, T. 2009. Ostreid herpes virus 1 
infection in families of the Pacific oyster, Crassostrea gigas, during a summer mortality out-
break: difference in viral DNA detection and quantification using real-time PCR. Virus Re-
search 142: 181–187. 
Sawabe, T., Inoue, S., Fukui, Y., Yoshie, K., Nishihara, Y. and Miura, H., 2007. Mass mortalities 
of Japonese abalone Haliotis diversicolor supertexta caused by Vibrio harveyi infection. Microbes 
and Environments 22: 300-308. 
Schikorski, D., Renault, T., Saulnier, D., Faury, N., Moreau, P. and Pepin, J.-F. 2011. Experimental 
infection of Pacific oyster Crassostrea gigas spat by ostreid herpesvirus 1: demonstration of 
oyster spat susceptibility. Veterinary Research 42: 27-40. 
Segarra, A., Pepin, J.F., Arzul, I., Morga, B., Faury, N. and Renault, T. 2010. Detection and de-
scription of a particular Ostreid herpesvirus 1 genotype associated with massive mortality 
outbreaks of Pacific oysters, Crassostrea gigas, in France in 2008. Virus Research 153: 92–95. 
Shimahara, Y., Kurita, J., Kiryu, I., Nishioka, T., Yuasa, K., Kawana, M., Kamaishi, T. and Oseko, 
N. 2012. Surveillance of Type 1 Ostreid Herpesvirus (OsHV-1) variants in Japan. Fish Pathol-
ogy 47: 129-136. 
48  | ICES Cooperative Research Report 337 
 
 
Sugumar, G., Nakai, T., Hirata, Y., Matsubara, D. and Muroga, K. 1998. Vibrio splendidus biovar 
II as causative agent of bacillary necrosis of Japanese oyster Crassostrea gigas larvae. Diseases 
of Aquatic Organisms 33: 111-118. 
Travers, M.A., Le Goic, N., Huchette, S., Koken, M. and Paillard, C., 2008. Summer immune de-
pression associated with increased susceptibility of the European abalone, Haliotis tubercu-
lata to Vibrio harveyi infection. Fish and Shellfish Immunology 25: 800-808. 
Van Banning, P. 1977. Minchinia armoricana sp. nov. (Haplosporida), a parasite of the European 
flat oyster, Ostrea edulis. Journal of Invertebrate Pathology 30: 199–206. 
Van Banning, P. 1990. The life cycle of the oyster pathogen Bonamia ostreae with a presumptive 
phase in the ovarian tissue of the European flat oyster, Ostrea edulis. Aquaculture 84 : 189-
192. 
Vilela, H. 1951. Sporozoaires parasites de la Palourde, Tapes decussatus (L.). Rev. Fac. Ciencias, 
Lisba, Sér C, 1, 379-386. 
Villalba, A., Mourelle, S.G., López, M.C., Carballal, M.J. and Azevedo, C. 1993. Marteiliasis af-
fecting cultured mussels Mytilus galloprovincialis of Galicia (NW Spain). I. Etiology, phases 
of the infection, and temporal and spatial variability in prevalence. Diseases of Aquatic Or-
ganisms 16: 61−72 
Villalba, A., Iglesias, D., Ramilo, A., Darriba, S., Parada, J.M., No, E., Abollo, E., Molares, J. and 
Carballal, M.J. 2014. Cockle Cerastoderma edule fishery collapse in the Ría de Arousa (Galicia, 
NW Spain) associated with the protistan parasite Marteilia cochillia. Diseases of Aquatic Or-
ganisms 109: 55-80. 
Virvilis, C. and Angelidis, P. 2003. Presence of the parasite Marteilia sp. in the flat oyster (Ostrea 
edulis L) in Greece. Aquaculture 259: 1-5. 
Wood, J.L. and Andrews, J.D. 1962. Haplosporidium costale (Sporozoa) associated with a disease 
of Virginia oysters. Science 136: 710-711. 
Wolf, P. H. 1972. Occurrence of a haplosporidian in Sydney rock oysters (Crassostrea commercialis) 
from Moreton Bay, Queensland, Australia. Journal of Invertebrate Pathology 19: 416-417. 
Wolf, P.H. 1979. Life cycle and ecology of Marteilia sydneyi in the Australian oyster, Crassostrea 
commercialis. Marine Fisheries Review 41: 70-72. 
Yanin, L., Kang, H.-S., Hong, H.-K., Jeung, H.-D., Kim, B.-K., Le, T.C., Kim, Y.-O. and Choi, K.-
S. 2013. Molecular and histological identification of Marteilioides infection in Suminoe oyster 
Crassostrea ariakensis, Manila clam Ruditapes philippinarum and Pacific oyster Crassostrea gigas 
on the south coast of Korea. Journal of Invertebrate Pathology 114: 277-284. 
 
 
 
 
 
 
 
 
 
 
New Trends in Important Diseases Affecting the Culture of Fish 
and Molluscs in the ICES Area 2002 – 2015 |  49 
 
 
Author contact information 
Anders Alfjorden 
National Veterinary Institute 
75189 Uppsala, Sweden 
anders.alfjorder@sva.se  
Stephen Feist 
Centre for Environment, Fisheries & 
Aquaculture Science (CEFAS) 
Barrack Road, The Nothe 
Weymouth, Dorset DT4 8UB, UK 
Stephen.feist@cefas.co.uk   
Marlene Areskog 
National Veterinary Institute 
75189 Uppsala, Sweden 
marlene.areskog@sva.se  
 
Susan Ford 
Rutgers University 
6959 Miller Avenue 
Port Norris, NJ 08349, USA 
sford@hsrl.rutgers.edu  
David Bruno 
University of Aberdeen 
Aberdeen AB24 2TZ, Scotland, UK 
david.bruno@abdn.ac.uk  
 
Simon Jones 
Fisheries and Oceans Canada 
3190 Hammond Bay Road 
Nanaimo, BC, V9T 6N7, Canada 
simon.jones@dfo-mpo.gc.ca  
Ryan Carnegie 
Virginia Institute of Marine Science 
P.O. Box 934 
Gloucester Point 
Virginia 23062, USA 
carnegie@vims.edu  
Atle Lillehaug 
Norwegian Veterinary Institute 
P.O. Box 750 Sentrum 
0106 Oslo, Norway 
atle.lillehaug@vetinst.no  
Deborah Cheslett 
Marine Institute  
Oranmore 
Co Galway H91 R673, Ireland 
deborah.cheslett@marine.ie  
Lone Madsen 
Technical University of Denmark 
National Veterinary Institute 
Bülowsvej 27, 1870 Frederiksberg C, 
Denmark 
loma@vet.dtu.dk  
 
 
 
 
 
 
50  | ICES Cooperative Research Report 337 
 
 
Tristan Renault 
The French Research Institute for Exploi-
tation of the Sea (IFREMER) 
La Tremblade 17390, France 
tristan.renault@ifremer.fr   
Pia Vennerström 
Finnish Food Safety Authority (EVIRA) 
Mustialankatu 3 
00790 Helsinki, Finland 
pia.vennerstrom@evira.fi  
Neil Ruane 
Marine Institute 
Oranmore  
County Galway H91 R673, Ireland 
neil.ruane@marine.ie  
 
 
 
 
